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I enjoy talking with very old people. They have gone before us on a road by which 
we, too, may have to travel, and I think we do well to learn from them what it is like. 
- Socrates, in Plato’s The Republic
Sari Stenholm, Obesity as a risk factor for walking limitation in older Finnish men 
and women. Mediating factors, long-term risk and coexisting conditions. 
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ABSTRACT
Walking is a critical component in maintaining independent and high quality of life 
in old age, and difficulties in walking often precede more severe disability. Obesity 
is a known risk factor for several diseases, but a limited number of studies have 
examined the negative effect of obesity on walking or general mobility. Moreover, 
relatively little is known about the possible mechanisms through which obesity 
affects walking performance. This study was conducted to explore obesity as a risk 
factor for walking limitation, and to examine the role of different diseases and 
biological indicators in that association. Furthermore, obesity and physical 
impairments were studied as long-term risk factors in predicting limitations in later 
life walking.  
This study targeted Finnish men and women aged 55 years or older, and it was based 
on the nationwide cross-sectional population-based Health 2000 Survey (n = 3 392) 
and the prospective Mini-Finland Follow-up Survey with a 22-year follow-up 
(n = 1 278). Walking limitation was defined as measured maximal walking speed 
less than 1.2 m/s, supplemented with self-reported difficulty in walking 500 meters 
for those who did not take part in the walking speed test. In the health examination 
of the Health 2000 Survey, body composition, body mass index, waist 
circumference, and handgrip strength were measured, medical conditions were 
diagnosed by a physician, and a blood sample was drawn. Recalled height at the age 
of 20 years and recalled weight at the ages of 20, 30, 40 and 50 years were recorded. 
At the baseline of the Mini-Finland Follow-up Survey, body mass index, handgrip 
strength and ability to squat were measured, and ability to run 500 meters was 
elicited. The main statistical method used in this study was logistic regression 
analysis. 
In the cross-sectional setting, overweight and obesity were independently associated 
with walking limitation, more strongly in women than in men. Type 2 diabetes in 
men and knee osteoarthritis in women were the diseases which contributed most to 
the association between obesity and walking limitation. In addition, increased C-
reactive protein level and low handgrip strength were found to mediate the 
association between high body fat percentage and walking limitation. The 22-year 
follow-up study showed that high body mass index and physical impairments 
measured at middle-age predicted walking limitation in later life. Based on a 
retrospective design, obesity duration over several decades increased the risk of 
walking limitation. Finally, overweight or obese persons with coexisting diseases or 
physical impairments had a high risk of current or future walking limitation 
compared with the risk associated with excess body weight alone.  
The findings of this study show that obesity and obesity duration throughout the 
lifespan as well as obesity and coexisting conditions are important risk factors 
influencing walking in older person. The results of the present study may be useful 
when planning and targeting efficient interventions to prevent and alleviate walking 
limitation in older people. Future research using prospective and experimental 
settings is needed to confirm the role of diseases, low-grade inflammation, and 
decreased muscle strength in the pathway from obesity to walking limitation.  
Keywords: body composition, coimpairment, comorbidity, epidemiological studies, 
inflammation, mobility, muscle strength, obesity, older people, walking 
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TIIVISTELMÄ 
Kävelykyky vaikuttaa olennaisesti ikääntyvän ihmisen elämänlaatuun ja hänen 
edellytyksiinsä selviytyä ilman muiden apua. Usein kävelyvaikeudet ennustavat 
vielä vaikeampien toiminnanvajavuuksien ilmaantumista. Lihavuus on monien sai-
rauksien tunnettu riskitekijä, mutta lihavuuden kielteisiä vaikutuksia kävelykykyyn 
on tutkittu vähän. Tietoa on niukasti myös niistä mekanismeista, joiden välityksellä 
lihavuus rajoittaa kävelykykyä. Tässä tutkimuksessa tarkasteltiin lihavuutta kävely-
vaikeuksien riskitekijänä ja samalla myös erilaisten biologisten tekijöiden ja kroo-
nisten sairauksien osuutta lihavuuden ja kävelyvaikeuksien väliseen yhteyteen. Li-
säksi tutkittiin miten keski-iällä todettu lihavuus ja heikentynyt fyysinen suoritus-
kyky ennustavat kävelyvaikeuksien ilmaantumista myöhemmällä iällä. 
Tutkimuksen kohdejoukkona olivat 55 vuotta täyttäneet suomalaiset miehet ja nai-
set. Tutkimus perustui suomalaista aikuisväestöä edustavaan Terveys 2000 -tutki-
mukseen (n = 3 392) sekä sen yhteydessä tehtyyn seurantatutkimukseen (n = 1 278), 
jossa tutkittiin 22 vuotta aikaisemmin Mini-Suomi -tutkimukseen osallistuneita 
henkilöitä. Tutkittavan kävelyn katsottiin olevan vaikeutunutta, jos hänen maksi-
maalinen kävelynopeutensa oli alle 1.2 m/s tai mikäli tutkittava ei osallistunut 
kävelynopeustestiin, hän ilmoitti vaikeuksia 500 metrin kävelyssä. Terveys 2000  
-tutkimuksessa mitattiin kehon koostumus, painoindeksi, vyötärönympärys ja käden 
puristusvoima. Lisäksi lääkäri diagnosoi tutkittavan sairaudet kliinisen tutkimuksen 
perusteella ja häneltä otettiin verinäyte. Tutkittavalta kysyttiin myös hänen pituut-
taan 20 vuoden iässä ja painoa 20-, 30-, 40- ja 50-vuotiaana. Mini-Suomi -tutkimuk-
sen lähtötilanteessa mitattiin painoindeksi, käden puristusvoima ja kyykistymiskyky 
sekä tiedusteltiin tutkittavan suoriutumista 500 metrin juoksemisesta. Pääasiallisena 
tilastomenetelmänä tutkimuksessa käytettiin logistista regressioanalyysia. 
Poikkileikkausasetelmassa ylipainon ja lihavuuden havaittiin olevan itsenäisesti yh-
teydessä kävelyvaikeuksiin, selvemmin naisilla kuin miehillä. Kroonisista sairauk-
sista lihavuuden ja kävelyvaikeuksien välistä yhteyttä selittivät parhaiten miehillä 
tyypin 2 diabetes ja naisilla polvinivelrikko. C-reaktiivisen proteiinin kohonneen 
pitoisuuden ja käden puristusvoiman heikkouden todettiin vastaavasti välittävän ke-
hon korkean rasvaprosentin ja kävelyvaikeuksien välistä yhteyttä. 22 vuoden seu-
rannassa keski-iällä todetun korkean painoindeksin ja huonon fyysisen suoritus-
kyvyn havaittiin ennustavan kävelyvaikeuksien ilmaantumista myöhemmällä iällä. 
Retrospektiivisessä tarkastelussa ilmeni, että pitkään jatkunut lihavuus lisäsi kävely-
vaikeuksien riskiä. Kävelyvaikeuksien riski oli selvästi suurempi niillä ylipainoisilla 
ja lihavilla henkilöillä, joilla oli samanaikaisia sairauksia tai fyysisen suorituskyvyn 
heikkouksia verrattuna niihin, joilla ei sellaisia ollut. 
Tämän edustavaan väestöaineistoon perustuvan tutkimuksen tulokset osoittavat, että 
tutkimushetkellä havaittu ja pitkään kestänyt lihavuus sekä sen ohessa saman-
aikaisesti esiintyvät krooniset tilat ovat merkittäviä ikääntyvien henkilöiden 
liikkumiskyvyn riskitekijöitä. Tutkimuksen tulokset voivat palvella ikääntyvien ih-
misten kävelyrajoitusten ennaltaehkäisyyn ja lieventämiseen suunnattujen interven-
tioiden suunnittelua. Kroonisten sairauksien, lieväasteisen tulehduksen ja heikon 
lihasvoiman merkitys lihavuuden ja kävelyvaikeuksien välisen yhteyden selittäjinä 
on syytä vielä varmistaa uusilla pitkittäisaineistoihin ja kokeellisiin tutkimusasetel-
miin perustuvilla lisätutkimuksilla.  
Avainsanat: epidemiologiset tutkimukset, fyysinen kunto, ikääntyneet, 
inflammaatio, kehon koostumus, kävely, lihasvoima, lihavuus, liikkumiskyky, 
moniongelmaisuus, monisairastavuus 
CONTENTS
ABBREVIATIONS.............................................................................................11
LIST OF ORIGINAL PUBLICATIONS ............................................................12
1 INTRODUCTION........................................................................................13
2 REVIEW OF THE LITERATURE..............................................................15
2.1 Walking as part of functional capacity ...............................................15
2.2 Obesity and body composition............................................................20
2.3 The effect of obesity on walking limitation ........................................22
2.4 Mediating factors between obesity and walking limitation ................24
2.5 Coexisting conditions and walking limitation ....................................26
3 AIMS OF THE STUDY...............................................................................28
4 MATERIALS AND METHODS.................................................................29
4.1 Study designs and participants............................................................29
4.2 Study variables and definitions...........................................................33
4.3 Statistical methods ..............................................................................39
5 RESULTS ....................................................................................................42
5.1 The characteristics of the study populations .......................................42
5.2 Prevalence of walking limitation by obesity indicators (I–III) ...........44
5.3 Mediating factors between obesity and walking limitation (I, II).......46
5.4 Long-term risk of walking limitation in relation to obesity and 
physical impairments (III, IV) ............................................................49
5.5 The effect of coimpairment and comorbidity on walking limitation 
(I, II, IV)..............................................................................................50
6 DISCUSSION ..............................................................................................54
6.1 Obesity and walking limitation: mediating factors, long-term risk 
and coexisting conditions....................................................................54
6.2 Methodological considerations ...........................................................61
6.3 Future directions .................................................................................66
7 MAIN FINDINGS AND CONCLUSIONS.................................................67
8 ACKNOWLEDGEMENTS .........................................................................68
9 REFERENCES.............................................................................................70
APPENDIX TABLE ...........................................................................................89
ORIGINAL PUBLICATIONS I–IV ...................................................................95
11
ABBREVIATIONS 
ADL  Activities of daily living 
BIA  Bioelectric impedance analysis 
BMI  Body mass index 
CI  Confidence interval 
CRP  C-reactive protein 
CT  Computed tomography 
CV  Coefficient of variation 
DXA  Dual energy X-ray absorptiometry 
ICC  Intra-class correlation 
IL-6  Interleukin-6 
MRI  Magnetic resonance imaging 
OR  Odds ratio 
r  Pearson correlation coefficient 
ROC  Receiver operator characteristics  
SD  Standard deviation 
TNF-?  Tumor necrosis factor-?
WC  Waist circumference 
WHO  World Health Organization 
WHR  Waist-to-hip ratio 
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1 INTRODUCTION
The “graying of Finland” is proceeding at a rapid pace. The current population 
projection suggests that the proportion of people aged 55 years or older will rice 
from 30% in year 2005 to 39% in 2040 (Statistics Finland 2006). Relatively similar 
trends are expected in other European countries, as well (Nieminen and Koskinen 
2006). Despite the fact that older adults are healthier today than ever before 
(Aromaa et al. 2006), with advancing age the possibility of diseases, impairments, 
limitations, and disabilities increases. One of the most essential features of older 
people’s independent functioning in daily life is mobility. Different aspects of 
mobility include for example ability to walk, climb stairs, and use public 
transportation. In the Health 2000 Survey, 8% of men and women aged 55–64 years 
and 41% of men and 52% of women aged 75–84 years reported difficulties in 
walking 500 meters (Sainio et al. 2006), indicating that walking limitation increases 
with age and is more common in women than in men. Loss of mobility seriously 
threatens the independence and quality of life of older adults (Ostir et al. 1998; 
Guralnik et al. 2000). Moreover, persons with walking limitation are less likely to 
remain in the community, have higher rates of mortality (Guralnik et al. 1994; 
Hirvensalo et al. 2000; Penninx et al. 2000; Cesari et al. 2005a) and thus need more 
social and health care services (Fried et al. 2001a). Consequently, prevention or 
postponement of walking limitation is a high priority and this requires the 
identification of modifiable risk factors in the older population.  
Obesity is one of the potentially modifiable risk factors of walking limitation. 
Obesity is a rising health problem in western countries, as well as in non-
industrialized countries, particularly in those undergoing economic transition 
(Visscher and Seidell 2001). In Finland, the prevalence of obesity (body mass index 
[BMI] ? 30 kg/m2) has increased markedly in the adult population over the last few 
decades: from 12% in men and 17% in women during the late 1970s to 21% in men 
and 23% in women at the beginning of the 21st century (Aromaa and Koskinen 
2004). While the associations between obesity and several diseases are well-
established and have been studied for decades, the effect of obesity on older 
persons’ functional capacity has only more recently gained more systematic 
scientific attention. To date, only few studies have examined the negative effect of 
obesity on walking limitation, and relatively little is known of the possible reasons 
why obesity is a risk factor for poor walking performance.  
Excess weight can be considered as a mechanical load which causes wear and tear 
on joints and reduces flexibility. The energy expenditure and oxygen consumption 
of an obese person engaged in a similar physical task are higher than of a normal 
weight person, and thus place increased demands on aerobic capacity, potentially 
limiting physical performance (Hulens et al. 2001; Hulens et al. 2003). In addition, 
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due to the age-related decrease in muscle mass (Janssen et al. 2000), decreased 
muscle strength relative to body weight may cause difficulties in weight-bearing 
activities among older obese persons. Beyond these physical factors, it is likely that 
obesity influences walking limitation through medical conditions. Obesity is known 
to be an independent risk factor for several diseases (Pi-Sunyer 1993), such as type 2 
diabetes, cardiovascular diseases, and knee osteoarthritis, which often restrict 
mobility (Stuck et al. 1999; Bootsma-van der Wiel et al. 2002). Moreover, several 
biological indicators related to the immune system and hormonal responses correlate 
with the amount of adipose tissue (Cesari et al. 2005b; Bastard et al. 2006). The 
association of these indicators with functional outcomes is currently under intensive 
investigation (Seplaki et al. 2004), thus providing new hypotheses about the 
pathway from obesity to walking limitation. 
According to the Health 2000 Survey, the population segment with the highest 
prevalence of obesity consists of adults around retirement age. At the beginning of 
the 21st century, 28% of men aged 55–64 years and 34% of women aged 65–74 
years were obese (Aromaa and Koskinen 2004). Obesity is also becoming 
increasingly common in young adulthood and middle-age. Earlier studies have 
found that in addition to current obesity, previous obesity and early onset of obesity 
may have adverse effects on older persons’ health (Jousilahti et al. 1999; Field et al. 
2001; Jeffreys et al. 2005). However, only a few studies have examined the long-
term risk of obesity in earlier life on disability in later life (Guralnik and Kaplan 
1989; Keil et al. 1989; Hubert et al. 1993; Vita et al. 1998; Ferraro et al. 2002; 
Strandberg et al. 2003; Peeters et al. 2004).  
The present study was conducted to obtain knowledge about obesity as a risk factor 
for walking limitation in older adults. The specific objectives were to examine the 
role of diseases and biological indicators in the association between obesity and 
walking limitation, as well as to study obesity, in terms of duration of obesity, 
midlife obesity and physical impairments, as long-term risk factors in predicting 
walking limitation in later life. This study targeted Finnish men and women aged 55 
years or older, and was based on the nationwide cross-sectional population-based 
Health 2000 Survey and the prospective Mini-Finland Follow-up Survey with a 22-
year follow-up.  
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2 REVIEW OF THE LITERATURE 
2.1 Walking as part of functional capacity 
Functional capacity is a central aspect of health and well-being among older 
persons. In Finland, the importance of this issue has also been recognized lately on 
the policy level, and promotion of the functional capacity of older persons has been 
emphasized in the national public health program Health 2015 (Government 
Resolution on the Health 2015 public health programme 2001). The term functional 
capacity refers to the ability to perform tasks and activities that people find 
necessary or desirable in their lives. It is a multidimensional concept and is often 
divided into physical, psychological, and social components. The negative aspect of 
functional capacity, disability, has been defined as the inability to perform or 
complete particular tasks or roles without difficulty or the help of another person 
(Verbrugge and Jette 1994). Moreover, disability can be seen as a difference or gap 
between an individual’s ability to complete a particular task and the demands of the 
task (Schroll 1994).
Various conceptual models of functional capacity have been proposed. The most 
widely used conceptualization is the disablement process, which is based on the 
model initially proposed by Nagi (1965; 1976) and further extended and elaborated 
among others by Verbrugge and Jette (1994) (Figure 1). The main pathway in the 
disablement process is presented as sequential events starting from pathology 
(e.g. chronic diseases) proceeding to the generation of impairments (e.g. decreased 
muscle strength and aerobic capacity), and consequent functional limitations 
(e.g. restrictions in walking), and ending to disability (e.g. difficulties in performing 
the activities of daily living [ADL]). The key concept in the disablement process is 
functional limitation, the state between impairment and disability. It is defined as 
limitation in performance at the level of the whole organism or person (Nagi 1991), 
in which the individual’s overall ability to perform various activities is limited. 
Although functional limitation is often a direct consequence of pathology and 
impairment, it may also arise as a direct or indirect result of prior predisposing risk 
factors, such as sociodemographic, lifestyle, and behavioral characteristics of an 
individual (Verbrugge and Jette 1994). In addition, intra-individual factors such as 
lifestyle and behavioral changes and psychosocial attributes, and extra-individual 
factors such as medical care, rehabilitation, external supports and environment may 
either reduce or increase functional limitation or disability. 
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Figure 1. A model of the disablement process (Verbrugge and Jette 1994). 
In clinical and epidemiological research on older persons, there are several 
advantages in focusing on the assessment of functional limitations. First, 
recognizing functional limitations is important because they predict more adverse 
outcomes such as subsequent disability (Guralnik et al. 1995; Ostir et al. 1998; 
Guralnik et al. 2000), hospitalization (Guralnik et al. 1994; Penninx et al. 2000), and 
mortality (Guralnik et al. 1994; Hirvensalo et al. 2000). Secondly, a functional 
limitation represents an outcome that is relatively free of the cultural and 
environmental influences which are likely to have a large impact on people’s 
experiences of disability. Thus, functional limitation serves a valid outcome to 
indicate the effect of diseases, impairments, and other risk factors on functional 
capacity (Guralnik and Ferrucci 2003). Finally, persons with physical functional 
limitations appear to be a good target group for physical exercise interventions. 
They are not so disabled that they are unable to participate in interventions, and 
neither are they so healthy and well-functioning that small intervention effects 
cannot be detected (Guralnik and Ferrucci 2003; Keysor 2003).  
In the present study, the focus is on one important aspect of functional limitation, 
namely walking limitation. Walking is a central part of daily functioning and a 
critical prerequisite of independent living. In gerontological research, walking 
performance has been found to be a very suitable indicator of functional limitation 
(Cesari et al. 2005a). In addition, walking as an activity is universal and little 
influenced by cultural differences; therefore it enables valid international or 
intercultural comparisons (Lan et al. 2003). Several studies during the last decade 
have found that walking limitation is a major risk factor for difficulty and 
dependency in other domains of physical functioning (Ostir et al. 1998; Guralnik et 
al. 2000; Shinkai et al. 2000) as well as to falling (Covinsky et al. 2001; Montero-
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Odasso et al. 2005). In addition, walking limitation or impaired lower extremity 
performance predicts hospitalization and mortality (Guralnik et al. 1994; Hirvensalo 
et al. 2000; Penninx et al. 2000; Cesari et al. 2005a).  
Determinants of walking limitation 
Smooth and controlled walking performance is dependent on the integration of 
multiple physiological, cognitive, and psychological characteristics. From the 
physiological point of view, walking is determined and coordinated by 
musculoskeletal, cardio-respiratory, sensory, and neural systems (Sakari-Rantala et 
al. 1998). Two most important prerequisites for walking are lower extremity muscle 
strength and postural balance (Rantanen et al. 1999a; Tiedemann et al. 2005). These 
are needed to generate continuous movement to progress forward and to maintain an 
upright body posture during progression (Woollacott and Tang 1997). In addition to 
sufficient strength, walking performance requires the ability to generate force at high 
velocity in response to changing environmental and task demands. There is evidence 
that decreased muscle power (power = force x velocity) rather than decreased 
strength is more closely associated with impaired walking performance (Bean et al. 
2003; Sayers et al. 2005). Furthermore, it has been suggested that lower extremity 
muscle strength and power are not linearly associated with walking speed, but 
instead, there are thresholds, and above a certain threshold, an increase in strength or 
power does not have the effect of an increasing on walking speed (Buchner et al. 
1996; Ferrucci et al. 1997; Rantanen et al. 1998a).  
In addition to impaired muscle strength and postural stability, decreased aerobic 
capacity and reduced range of motion in the lower extremity joints may restrict 
walking performance (Kerrigan et al. 1998; Bean et al. 2002). Also impaired vision, 
especially distant visual acuity and contrast sensitivity, as well as increased reaction 
time may cause difficulties in maintaining stability and responding to environmental 
changes while walking (Sakari-Rantala et al. 1998; Cromwell et al. 2002; 
Tiedemann et al. 2005).  
Other underlying causes of poor walking performance include diseases and other 
medical conditions. Potentially fatal diseases that are known to cause mobility 
limitation are coronary heart disease through its manifestations of angina pectoris 
and myocardial infarction as well as through its complications, such as heart failure 
(Guralnik et al. 1993; Bootsma-van der Wiel et al. 2002). Also hypertension, 
claudication, stroke, pulmonary diseases, and type 2 diabetes are strong predictors of 
walking limitation through their effects on the cardiopulmonary and peripheral 
nervous system (Guralnik et al. 1993; Gregg et al. 2002; Volpato et al. 2003; Al 
Snih et al. 2005; Figaro et al. 2006; Shah et al. 2006). Of the nonfatal diseases, 
arthritis is the leading cause of mobility limitation. In particular painful arthritis in 
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the lower extremities may strongly limit mobility (Ettinger et al. 1994; Ling et al. 
2003).  
According to the model of the disablement process presented by Verbrugge and Jette 
(1994), there are several other risk factors that may cause functional or walking 
limitation either independently or through the above mentioned diseases and 
physical impairments. Risk factors related to health behavior causing functional 
limitation include smoking, heavy alcohol use, obesity, and physical inactivity 
(Ebrahim et al. 2000; Wannamethee et al. 2005a; Cawthon et al. 2007). With regard 
to older persons’ walking ability, physical activity has a major role in maintaining 
physical performance (Keysor 2003). Furthermore, due to an almost epidemic 
increase in obesity in the western countries, obesity has been acknowledged as a 
major risk factor for functional limitation in older people (Zamboni et al. 2005). 
Measurement of walking limitation 
The most obvious change in older persons’ walking is a substantial decrease in 
speed with age (Ferrandez et al. 1990). This has been found in both cross-sectional 
(Bohannon 1997; Sainio et al. 2006) and longitudinal studies (Seeman et al. 1994; 
Sonn et al. 1995; Era and Rantanen 1997). According to the nationally 
representative Health 2000 Survey, 7% of men and 11% of women aged 55–64 
years had a walking speed of less than 1.2 m/s, whereas in the age group 75–84 
years old the corresponding proportions were 49% and 67% (Sainio et al. 2006). The 
decline in walking speed is mainly due to decreased stride length and longer 
duration of the double-support phase where both feet are on the ground (Ferrandez 
et al. 1990; Ostrosky et al. 1994; Frank and Patla 2003). Besides the physiological 
restrictions in muscle strength, joint range of motion and vision can change the 
normal walking pattern, as well as poor balance and fear of falling may decrease 
walking speed and shorten stride length (Ferrandez et al. 1990; Alexander 1996).  
Walking ability in older persons can be measured in several ways, depending on the 
available equipments, room, time, and financial resources. Of the available physical 
performance measures, walking speed has been widely recognized as a good 
measure of mobility limitation both for healthy and impaired older persons 
(Guralnik et al. 1995). Because measurement of walking speed is quick, 
inexpensive, highly reliable, and sensitive to change it is a very practical method in 
the standard clinical setting as well as in large epidemiological studies (Onder et al. 
2002; Ostir et al. 2002; Cesari et al. 2005a). Moreover, as mentioned earlier, 
walking speed has high predictive validity for subsequent disability, hospitalization, 
and mortality (Guralnik et al. 2000; Cesari et al. 2005a). 
Currently, several test versions of measuring walking speed are used. First, the 
walking distance in the walking speed test varies between studies, the three most 
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often used distances are 2.4 meters (8 feet) (Guralnik et al. 1994; Markides et al. 
2001), 4 meters (Rantanen et al. 1999a; Studenski et al. 2003), and 6.0 or 6.1 meters 
(20 feet) (Bassey et al. 1992; Fiatarone et al. 1994; Visser et al. 2002a). In Finland a 
10-meter walking course is most often used (Sakari-Rantala et al. 1995; Avlund et 
al. 2006). Secondly, the subject can be instructed to walk at either maximal or usual 
pace. The first-mentioned indicates the capacity of the neuromuscular system, thus 
giving an idea of the individual’s potential to adapt to varying environmental and 
task demands (e.g. crossing a street), and the latter shows the normal performance 
level in everyday life. As can be seen, walking speed is usually measured using quite 
a short walking distance. However, long-distance walking tests provide more 
specific information about the aerobic capacity of older persons. The two most often 
used measures are the 6-minute walking test (Guyatt et al. 1985; Lord and Menz 
2002) and the long-distance corridor walk (400 m) (Simonsick et al. 2001a). 
Although these measures provide relevant information about the overall mobility 
and functional capacity of older persons (Bean et al. 2002; Lord and Menz 2002), 
they are not as widely used as the above-mentioned walking speed tests. This is 
mainly due to the longer test duration. 
In addition to objective walking tests, walking limitation can be assessed with self-
reported measures based on questionnaires and interviews; self-reports are often 
used in large-scale studies. In general, individuals are asked about their ability, 
difficulties, or need for help in walking a certain distance. The distances that are 
often used in questionnaires include 400 meters (1/4 mile or 2–3 blocks) (Hoeymans 
et al. 1996; Rantanen et al. 1999a; Sayers et al. 2004), 500 meters (Aromaa et al. 
1989; Sainio et al. 2006), and ½ mile (800 m) (Rosow and Breslau 1966; Guralnik et 
al. 1994; Reuben et al. 2004). These simple questions referring to a meaningful 
distance for older adults, as well as to long-distance walking tests, have been found 
to predict future disability (Guralnik et al. 1994; Reuben et al. 2004). 
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2.2 Obesity and body composition 
Definition and measurement of obesity and body composition 
Obesity is defined as a condition of abnormal or excessive fat accumulation in the 
adipose tissue, to the extent that health may be impaired (World Health Organization 
2000). Weight gain is caused by a positive energy balance stemming from an 
imbalance between energy intake and energy expenditure. The three major causes of 
this imbalance are metabolic factors, diet, and physical activity, and each of which is 
influenced by genetic traits (Weinsier et al. 1998). Body mass index (BMI), waist 
circumference, and waist-to-hip ratio (WHR) are so far the most commonly used 
anthropometric measures for the classification of general and central obesity (World 
Health Organization 2000). BMI, which was developed by the Belgian 
mathematician Quetelet in the 19th century, is a simple index measuring general 
adiposity and it is defined as weight in kilograms divided by height squared in 
meters (kg/m2). The World Health Organization (WHO) (2000) and the Expert Panel 
on the Identification, Evaluation, and Treatment of Overweight and Obesity in 
Adults (1998) have proposed an international classification of overweight and 
obesity which is based on results concerning the risk of morbidity and mortality 
according to relative weight in different populations. According to the WHO (2000), 
a BMI < 18.5 kg/m2 is defined as underweight, 18.5–24.9 kg/m2 as normal weight, 
25–29.9 kg/m2 as overweight, and ? 30 kg/m2 as obesity. Obesity can be further 
divided into moderate obesity (30–34.9 kg/m2), severe obesity (35–39.9 kg/m2), and 
very severe obesity (? 40 kg/m2).
Abdominal obesity can be easily assessed by measuring waist circumference and 
WHR. Waist girth is measured at the midpoint between the lower border of the rib 
cage and the iliac crest, and hip girth is assessed at the widest part of the pelvis. In 
epidemiological studies, classification of waist circumference and WHR are often 
based on gender and population specific percentiles (e.g. quartiles or quintiles), but 
general cut-off points to define increased health risks have also been presented. 
Widely used cut-off points for waist circumference are 1.02 meters in men and 
0.88 meters in women, and for WHR 1.0 in men and 0.85 in women (World Health 
Organization 2000). In Finland according to the Current Care guidelines (2002), for 
waist circumference the values of 1.00 meters for men and 0.90 meters for women 
are deemed to indicate increased health risk. To control for the effect of body height 
on waist circumference, waist-to-height ratio has also been proposed as a measure of 
abdominal fat (Han et al. 1997). However, it is not used as widely as waist 
circumference. When waist circumference and WHR have been compared, waist 
circumference has been found to have a higher correlation with the amount of 
visceral fat than WHR and a stronger association with poor health than WHR 
(Pouliot et al. 1994; Lean et al. 1995; Stewart et al. 2003). In addition, in older 
persons loss of muscle mass from the hip area may lead to overestimation of WHR 
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(Molarius and Seidell 1998). Therefore, it has been suggested that waist 
circumference could be used alone to indicate abdominal fat distribution. 
Several other tools are available for more detailed characterization of the obesity 
state. Body composition and body fat mass can be measured accurately, for example 
with underwater weighting and dual X-ray absorptiometry (DXA). The distribution 
of body fat can be measured in anatomical detail by using sophisticated imaging 
techniques, such as magnetic resonance imaging (MRI) and computed tomography 
(CT) (Jebb and Elia 1993; Goodpaster 2002). However, they are relatively difficult 
to use, and the costs of such techniques in terms of time and money limit their 
usefulness in large epidemiological studies and in routine clinical practice. 
Nevertheless, there are some exceptions. Bioelectrical impedance analysis (BIA), for 
example, provides valid body composition estimates at relatively low cost and it is 
easy to use and is not time-consuming (Jebb and Elia 1993; Kyle et al. 2004). 
Age-related changes in body composition 
When assessing obesity in an older population, age-related changes in 
anthropometrics and body composition must be taken into account. Body height 
declines with aging, faster in women than in men, mainly because of the loss of 
mineral content from the vertebral body due to osteoporosis and to the thinning of 
the inter-vertebral discs, which results from changes in the fibrocartilage quality of 
the annulus fibrosus and hydration level of the nucleus pulposus (Sorkin et al. 1999; 
Sagiv et al. 2000). There is little decline in height until the age of 40. However, 
height starts to decrease more strongly after the age of 60 in men and 50 in women 
(Sorkin et al. 1999). Sorkin et al. (1999) demonstrated that cumulative height loss 
from age 30 to 70 years averaged about 3 centimeters for men and 5 centimeters for 
women, and by age 80 years was around 5 centimeters for men and 8 centimeters for 
women. Contrary to body height, body weight tends to increase, peaking at about 
age 60 years in men and later in women (Noppa et al. 1980; Rissanen et al. 1988; 
Droyvold et al. 2006). This can be partly explained by the progressive decline in 
total energy expenditure with aging and it is primarily due to decreased physical 
activity and in part a decrease in the basal metabolic rate (Elia et al. 2000). 
In addition to an increase in fat mass, aging is also associated with a redistribution of 
fat in the body: visceral fat increases, while subcutaneous fat in other regions of the 
body decreases (Zamboni et al. 1997; Beaufrère and Morio 2000). Also the amount 
of fat in muscle increases (Ryan and Nicklas 1999; Goodpaster et al. 2000). After 
the age of 70 most persons experience a decrease in weight and the average loss is 
2–3 kilograms during each successive decade (Bassey 1998; Dey et al. 1999). Later 
life weight loss is mainly due to loss of lean body mass rather than decline in fat 
mass (Suominen 1997). Muscle mass begins to decline around the age of 30 years 
with a more accelerated loss after the age of 60 (Lexell et al. 1988; Janssen et al. 
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2000). The loss is greater in men than in women in both absolute terms and relative 
to body weight (Gallagher et al. 2000; Hughes et al. 2001). Physical sedentariness, 
hormonal changes, malnutrition, loss of neuromuscular function, and chronic 
diseases have been found to accelerate the loss of muscle mass (Morley et al. 2001; 
Doherty 2003; Roubenoff 2003). 
Adverse health effects related to obesity 
The negative effect of obesity on health is well-known. Both cross-sectional and 
longitudinal studies have shown that obesity is a major risk factor for 
type 2 diabetes, insulin resistance, elevated blood pressure, and coronary heart 
disease as well as for other chronic conditions such as osteoarthritis, cancer, sleep 
apnea, and some respiratory conditions (Pi-Sunyer 1993; National Institutes of 
Health 1998; World Health Organization 2000). Especially hazardous for metabolic 
disorders and coronary heart disease is excess fat in the abdominal area 
(Silventoinen et al. 2003; Wannamethee et al. 2005b). In addition to medical 
outcomes, obesity among older persons decreases physical functional capacity and 
quality of life (Han et al. 1998; Friedmann et al. 2001; Davison et al. 2002; Larsson 
et al. 2002; Houston et al. 2005a). In contrast, the relationship between overweight, 
obesity and mortality among older people remains controversial, mainly because of 
many confounding factors (Zamboni et al. 2005; Al Snih et al. 2007). Most studies 
have reported that obesity is associated with increased mortality, but moderate 
overweight does not seem to increase the risk of death (Heiat et al. 2001). 
2.3 The effect of obesity on walking limitation 
A growing number of studies have found that excess body weight among older 
people is associated with poor mobility, and it also exposes to subsequent mobility 
limitation (LaCroix et al. 1993; Launer et al. 1994; Ebrahim et al. 2000; Bannerman 
et al. 2002; He and Baker 2004; Jenkins 2004; Houston et al. 2005a; Angleman et al. 
2006; Mendes de Leon et al. 2006). The focus in the studies so far has been mainly 
on the association between BMI and mobility limitation. Few studies have been 
attempted on abdominal obesity measured by waist circumference, despite that there 
is a tendency towards an increase of abdominal fat with aging (Zamboni et al. 1997; 
Rössner 2001). However, according to recent cross-sectional (Ramsay et al. 2006) 
and prospective studies (Bannerman et al. 2002; Houston et al. 2005a; Angleman et 
al. 2006; Guallar-Castillón et al. 2007) a large waist circumference has been found 
to be related to mobility limitation; but non-significant association has also been 
reported (Visser et al. 1998a). Furthermore, some researchers have used BIA, DXA 
and CT as objective measures of body fat mass, and found an association between 
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body fat mass and mobility limitation (Visser et al. 1998a; Visser et al. 1998b; 
Broadwin et al. 2001; Sternfeld et al. 2002; Visser et al. 2002a; Visser et al. 2005; 
Lebrun et al. 2006; Ramsay et al. 2006).  
A summary of the studies that have examined the effect of obesity on mobility 
limitation is presented in Appendix 1. Most of these studies have been implemented 
for both men and women. However, only a few studies have examined the effect of 
obesity on mobility limitation separately in men and women. In studies where BMI 
was used as an explanatory variable, the association was found to be weaker in men 
than in women (Davison et al. 2002; Larrieu et al. 2004; Angleman et al. 2006), 
except in one study (LaCroix et al. 1993). There are also a few gender-stratified 
studies where waist circumference and body fat mass have been used as explanatory 
variables (Visser et al. 1998a; Broadwin et al. 2001; Angleman et al. 2006; Guallar-
Castillón et al. 2007). However, comparison of the results between men and women 
is more difficult due to gender-specific categorization of waist circumference and 
body fat mass. 
Due to the fact that a great majority of studies referred to in Appendix 1 are large-
scale epidemiological studies, the results are often based on self-reported body 
weight and height and/or self-reported difficulties in mobility-related tasks. There is 
evidence that people tend to underestimate their body weight and overestimate their 
body height, thus causing underestimation of BMI (Kuskowska-Wolk et al. 1992; 
Engstrom et al. 2003), and consequently also underestimation of the risk of mobility 
limitation associated with overweight and obesity. In addition, cognitive status and 
depressive symptoms may have an influence on self-reported mobility limitations 
(Kempen et al. 1996; Hoeymans et al. 1997), thus potentially causing 
misclassifications (Guralnik et al. 1994). In studies related to BMI or waist 
circumference, only Angleman et al. (2006), Davis et al. (1998), and Mendes de 
Leon et al. (2006) have used objectively measured indicators of obesity and 
mobility. Thus, there is need for further studies on the association between obesity 
and mobility limitation as well as on the effect of gender on that association, using 
objectively measured indicators of obesity and mobility limitation. 
As can be seen in Appendix 1, several longitudinal studies have been produced on 
the predictive role of obesity on subsequent mobility limitation. In addition to short-
term follow-up studies, it is important to gain knowledge about the potential risk 
factors in early adulthood and midlife to later mobility limitation. However, only 
two long-term follow-up studies where the follow-up time is longer than 10 years 
and the effect of previous obesity on later life walking limitation has been published 
(Launer et al. 1994; Ebrahim et al. 2000). In their study Launer et al. (1994) found 
that the 45- to 59-year-old and 60- to 74-year-old women in the highest BMI tertile 
had a two-fold higher risk for developing mobility limitation over an average 
follow-up 14 years than women in the lowest BMI tertile. In addition, Houston et al. 
(2005b) found that recalled weight at age 25 was significantly associated with 
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functional limitation in late adulthood, but no information about possible baseline 
functional limitation was available in their study. Furthermore, studies related to 
late-life ADL disabilities have shown that excess weight in middle age predicts late-
life disability (Guralnik and Kaplan 1989; Keil et al. 1989; Hubert et al. 1993; Vita 
et al. 1998; Ferraro et al. 2002; Peeters et al. 2004). In addition to obesity in midlife, 
early onset of obesity and obesity duration may have adverse effects on mobility in 
older persons. There is evidence that the risk of type 2 diabetes (Sakurai et al. 1999; 
Wannamethee and Shaper 1999; Janssen et al. 2004; Jeffreys et al. 2005) and 
metabolic syndrome (Janssen et al. 2004) increases with obesity duration. However, 
no previous studies have examined the effect of obesity history on walking 
limitation. 
2.4 Mediating factors between obesity and walking limitation 
Information on the possible mechanisms leading from obesity to mobility limitation 
is limited. A search of the literature found only two studies in which the possible 
mediators between obesity and mobility limitation were investigated (Clark and 
Mungai 1997; Jenkins 2004). The negative effect of obesity on mobility is probably 
multifactorial, and consists of different pathological states, i.e. chronic diseases, 
physical impairments, and lifestyle factors such as physical inactivity. In Figure 2 
(page 27), a hypothetical model of the effects of obesity on the pathway to walking 
limitation is presented. However, beyond the mediating factors presented in the 
model, excess body weight as such may decrease physical performance since the 
additional loading on the locomotor system increases energy expenditure and 
therefore oxygen consumption (Hulens et al. 2001; Hulens et al. 2003). Obesity may 
also cause strain, pain or reduced range of motion in the lower limb joints, friction 
of the skin or urinary incontinence, thus limiting walking or other weight-bearing 
activities such as stair climbing (Mommsen and Foldspang 1994; Messier et al. 
2005; Wearing et al. 2006). 
Presumably, medical conditions constitute one of the most important pathways from 
obesity to walking limitation. Obesity is known to be associated with several 
diseases, such as type 2 diabetes, heart diseases, hypertension, and osteoarthritis (Pi-
Sunyer 1993) which in turn are known risk factors for walking limitation (Guralnik 
et al. 1993; Stuck et al. 1999; Bootsma-van der Wiel et al. 2002). In a study on 30- 
to 70-year-old African-American women, diabetes, arthritis, pain, and visual 
impairment partially explained the association between high BMI and mobility 
difficulties (Clark and Mungai 1997). Moreover, Jenkins (2004) found that diseases, 
symptoms and strength impairment partially explained the relationship between 
BMI and mobility impairment among older Americans. Unfortunately, more 
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detailed information on the effect of individual diseases was not available in that 
study, as diseases formed a single group variable. 
In addition to diseases, there are several biological indicators related to the immune 
system and hormonal responses, which may partially explain the effect of obesity on 
walking limitation. Recently, an extensive number of associations between 
biological indicators and various functional outcomes has been proposed (Seplaki et 
al. 2004). One of the strongest predictors of functional decline is low-grade 
inflammation through its catabolic effects on muscle (Ferrucci et al. 2002; Kuo et al. 
2006). Cross-sectional and prospective studies have shown that increases in 
inflammatory markers, such as interleukin-6 (IL-6) and C-reactive protein (CRP), 
correlate with decreases in muscle mass and strength (Visser et al. 2002b; Pedersen 
et al. 2003; Cesari et al. 2005b; Schaap et al. 2006), as well as mobility limitation 
(Ferrucci et al. 2002; Cesari et al. 2004; Penninx et al. 2004; Figaro et al. 2006; Kuo 
et al. 2006). Moreover, low-grade inflammation has been found to be related to 
obesity (Festa et al. 2001; Forouhi et al. 2001; Cesari et al. 2005b; Thorand et al. 
2006). Research suggests that cytokines, for example IL-6 and tumor necrosis 
factor-? (TNF-?), are released into circulation from the adipose tissue (Mohamed-
Ali et al. 1997), and IL-6 further stimulates the production of acute-phase proteins, 
such as CRP in the liver (Baumann and Gauldie 1994). Thus, these factors might 
partially explain the association between excess body fat and inflammatory markers 
(Festa et al. 2001; Forouhi et al. 2001).  
An important determinant of walking performance, muscle strength, may also have 
an independent effect on an obese person’s physical performance beyond the effects 
of inflammation. In absolute terms, obese persons may have higher muscle strength 
than normal weight individuals. However, when adjusted for body size, muscle 
strength is often lower in obese than normal weight subjects (Wearing et al. 2006). 
Thus, decreased muscle strength relative to body weight often exposes obese 
persons to limitations in walking and other weight-bearing activities. In 
gerontological research, the presence of excess fat in combination with decreased 
muscle mass, i.e. sarcopenia, is called sarcopenic obesity (Baumgartner 2000; 
Roubenoff 2000). There is some evidence that sarcopenic obesity may be associated 
with impaired walking and precede the onset of disability (Baumgartner 2000; 
Baumgartner et al. 2004). However, non-significant associations have also been 
reported (Davison et al. 2002; Zoico et al. 2004). Currently, there is evidence that 
muscle strength may be more important than muscle mass as a determinant of 
functional limitation and health in older age (Visser et al. 2000; Visser et al. 2005; 
Newman et al. 2006), thus the hypothesis about the effect of concurrent obesity and 
low muscle strength on walking limitation needs to be investigated further. 
Health behavioral factors, especially physical inactivity may in part mediate the 
effect of obesity on walking limitation. Obesity and physical inactivity are known to 
be closely connected, as are physical activity and physical functional capacity 
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(Brach et al. 2003; Bernstein et al. 2004; Brach et al. 2004a). Obese persons tend to 
be physically more sedentary than normal weight persons. Furthermore, physical 
inactivity correlates with low muscle strength, decreased aerobic capacity and 
impaired balance, thus consequently impairing walking and other mobility-related 
activities.  
2.5 Coexisting conditions and walking limitation 
With aging, the prevalence of diseases increases markedly and may lead to the 
coexistence of multiple chronic conditions, commonly referred to as comorbidity. 
Fried et al. (2004) have defined comorbidity as the concurrent presence of two or 
more medically diagnosed diseases in the same individual. Similarly, older people 
may simultaneously have two or more physical impairments. This state is called 
coimpairment. Nowadays, the effects of a single disease or a single physical 
impairment on mobility are relatively well known, but there is a paucity of studies 
on the effect of comorbidity and coimpairment on functional limitation. Rantanen 
and coworkers (1999a; 2001) found that co-occurrence of low muscle strength and 
impaired balance in older women is associated with severe walking disability. In 
addition, they suggested that the negative effect of impairment in one physiological 
system may be compensated by good capacity in another physiological domain. 
Consequently, people with poor balance may manage to avoid walking difficulties if 
they have enough strength in the lower extremities. Furthermore, Cesari et al. (2006) 
reported that among older people aged 80 years or older, comorbidity, defined here 
as three or more coexisting conditions (diagnosed diseases or obesity), was 
associated with lower walking speed and poorer physical functioning than among 
those without comorbidity. Other researchers have similarly found that comorbidity 
or coimpairment increases the risk of disability and mortality more than do 
individual conditions (Verbrugge et al. 1989; Ettinger et al. 1994; Fried et al. 1999; 
Rantanen et al. 2000).  
However, the effect of obesity and coexisting conditions on adverse health outcome 
has been investigated in only two studies. Rantanen et al. (2000) reported that the 
combination of overweight and low muscle strength caused the highest risk of death 
during a 30-year follow-up among initially healthy men compared with other BMI 
and muscle strength combinations. Similarly, Ettinger et al. (1994) found that obese 
people with knee osteoarthritis had increased risk of subsequent mobility limitation 
10 years later. Further studies on obesity and coexisting conditions and their effect 
on walking limitation are needed to recognize more potential high risk groups 
among obese persons. 
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The hypothetical model presented in Figure 2 illustrates the potential pathways from 
obesity to walking limitation discussed in the previous chapters. The model is based 
on the theoretical model of the disablement process presented by Verbrugge and 
Jette (1994) and it enables to locate the mediating and confounding factors between 
obesity and walking limitation in the right order relative to each other in the 
disablement process. Furthermore, the main concepts and the focus of this study are 
also shown in Figure 2. Besides the mediating factors, the association between 
obesity and walking limitation will be studied by different obesity subgroups, such 
as concurrent obesity and chronic diseases and obesity and low muscle strength. 
Figure 2. A hypothetical model showing the potential pathways from obesity to 
walking limitation. 
28
3 AIMS OF THE STUDY 
This study was conducted to explore obesity as a risk factor for walking limitation, 
and to examine the role of chronic diseases and biological indicators in that 
association among Finnish men and women aged 55 years or older. In addition, 
obesity and physical impairments were studied as long-term risk factors in 
predicting walking limitation in later life.  
The specific objectives of this study were: 
1. To describe the association between different obesity indicators and walking 
limitation among men and women (Studies I and II). 
2. To study whether chronic diseases and biological indicators mediate the 
association between obesity and walking limitation (Studies I and II). 
3. To investigate obesity duration, midlife obesity and physical impairments as 
long-term risk factors on walking limitation in later life (Studies III and IV). 
4. To study the effect of comorbidity and coimpairment on walking limitation 
(Studies I, II, and IV). 
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4 MATERIALS AND METHODS 
4.1 Study designs and participants 
The Health 2000 Survey 
The Health 2000 Survey is a comprehensive nationwide health interview and 
examination survey which was implemented in Finland in 2000–2001 (Aromaa and 
Koskinen 2004). The two-stage stratified cluster sample comprised individuals aged 
30 years and older living in mainland Finland either in the community or in 
institutions. The frame was regionally stratified according to the five university 
hospital districts, each containing approximately one million inhabitants. From each 
university hospital region, 16 health care districts were sampled as clusters. The 15 
largest cities were all included in the sample with a probability of one, and the 
remaining 65 health care districts were selected by applying the systematic 
probability proportional to size method. Finally, from these 80 clusters (including 
160 municipalities), a sample of 8 028 persons was selected by systematic sampling 
(Figure 3). In order to obtain a sufficient number of older people, persons aged 80 
years or older were over-sampled (2:1) in relation to their proportion in the 
population. The study population for the present study was limited to persons aged 
55 years or older (range 55–99 years), and consisted of 3 439 persons, of whom 
3 392 persons, 1 337 men and 2 055 women, were alive on the day of the first phase 
of the survey. 
Figure 3. Study areas of the Health 2000 
Survey. The boundaries of the 
university hospital districts are 
marked in bold line and the 
participating municipalities are 
shown in color on the map. 
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 A structured health interview with a mean duration of 95 minutes was completed at 
the participant’s home, eliciting information about the person’s health, illnesses, and 
functional ability as well as sociodemographic and health behavioral factors. If the 
person did not participate in the main interview, a supplementary interview was 
conducted later or eventually a questionnaire was sent. The overall participation rate 
in the health interview was 94% (n = 3 186). A few weeks later the participant 
attended a comprehensive health examination in a health centre. This examination 
consisted of several components such as measurement of anthropometry, functional 
capacity, and laboratory tests (n = 2 572, 76% of the sample). In addition, a 
structured clinical examination by a physician was completed. An abbreviated health 
examination was conducted at home or in an institution for those who did not 
participate in the study center examination (n = 306, 9% of the sample). After the 
examinations, a final interview was conducted and a nurse checked that the person 
had attended every planned measurement and that questionnaires had been properly 
filled in. In addition, during the health interview, the participant was given a 
questionnaire, which was to be returned on arrival at the health examination. This 
questionnaire included information for example about weight history and alcohol 
use, and was returned by 2 845 persons (89%). A detailed description of the study 
design, data collection methods, and health and functional status of the study 
population has been reported elsewhere (Aromaa and Koskinen 2004).  
The Mini-Finland Follow-up Survey 
The Mini-Finland Follow-up Survey is based on the population-based Mini-Finland 
Health Examination Survey implemented in 1978–1980. The baseline study 
population was a stratified two-stage cluster sample drawn from the national 
population register to represent Finnish adults aged 30 years or older (Aromaa et al. 
1989). In the first stage, 40 representative areas were selected and within these areas 
a sample of 8 000 individuals (3 637 men and 4 363 women) were selected by 
systematic sampling. A total of 7 217 subjects (90% of the sample) participated. The 
survivors (n = 1 278) who were living in the seven selected large municipalities out 
of the original 40 in 2000–2001 were invited to take part in the follow-up study, 
which was executed as part of the Health 2000 Survey. The present study was 
limited to persons who reported no walking limitation (were able to walk 
500 meters) and were not pregnant at the baseline, and who were 55 years or older at 
follow-up (n = 954). Only 11.9% (n = 114) of the eligible sample were not able or 
unwilling to participate in the follow-up. 
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The health examinations of the Mini-Finland Health Examination Survey were 
performed in two phases (Aromaa et al. 1989; Mäkelä et al. 1991). In a screening 
phase, a specific structured interview for symptoms was executed, and several 
examinations, including blood pressure measurements and blood sampling, were 
performed. In addition, a standardized joint function test for musculoskeletal 
impairment and a questionnaire on mental symptoms were administrated. 
Participants with a history of a disease, symptoms or findings suggestive of a 
musculoskeletal, cardiovascular, respiratory, or mental disorder were invited to 
participate in the main examination. This consisted of supplementary interviews, 
measurements and a standardized examination by a physician. Details of the design 
and implementation of the Mini-Finland Health Examination Survey have been 
reported elsewhere (Aromaa et al. 1989).  
All the participants in the Health 2000 Survey as well as the Mini-Finland Follow-
up Survey signed a written informed consent and the studies were approved by the 
Ethical Committee for epidemiology and public health in the hospital district of 
Helsinki and Uusimaa in Finland. The data and the inclusion criteria used in the 
original publications are shown in Table 1. 
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4.2 Study variables and definitions 
A summary of the variables used in the analyses in the original studies is presented 
in Table 2. The variables and their measurement are described in more detail in the 
original studies (I–IV). 
Table 2. The variables used in the analyses in the original studies 
Variable Study Reference for method  Reliability 
Outcome variables 
Maximal walking speed on 6.1 m 
(H)
I–IV (Fiatarone et al. 1994;  
Sainio et al. 2005)  
ICC = 0.77, n = 153 (Sainio et al. 2006) 
Self-reported difficulty in walking 
500 m (I) 
I–IV (McWhinnie 1981;  
Aromaa et al. 1989) 
Walking limitation I–IV See description on the page 35  
Explanatory variables 
BMI (body weight and height)  
(H, Q) 
I–III Weigth: Biospace, Inbody 3.0 
or portable spring scale;  
Height: Person-Check, 
Medizintechnik, KaWe 
(Germany) or wall measure  
BMI (body weight and height) IV Weigth: spring scale 
Height: wall measure 
Waist circumference (H) II (Reunanen 2005) ICC = 0.95, n = 92 (Reunanen 2005) 
Body composition  
(body fat percentage) 
II Biospace, Inbody 3.0 (Seoul, 
South-Korea)  
(Heliövaara 2005) 
Body height at age 20 years (Q) III (Aromaa and Koskinen 2004)  
Body weight at age 20, 30, 40 and 
50 years (Q) 
III (Aromaa and Koskinen 2004)  
Handgrip strength IV Bruel-Kjaer Type 1526 
(Denmark) (Mälkiä 1983) 
Repeatability over 3 months,  
r = 0.91–0.93, n = 449 (Mälkiä 1983) 
Squatting IV (Sievers et al. 1985)  Repeatability over 3 months, ? =0.66,  
n = 793 (Heliövaara et al. 1993) 
Self-reported difficulty in running 
500 m (Q) 
IV (Mälkiä 1983) Repeatability over 3 months,  
? = 0.59, n = 392 (Mälkiä 1983) 
Continued overleaf 
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Table 2 continued 
Variable Study Reference for method  Reliability 
Mediating variables    
C-reactive protein II Ultra-sensitive immunoturbido-
metric test (Orion Diagnostica, 
Espoo, Finland) and the Optima 
analyzer (Thermo Electron 
Corporation, Vantaa, Finland) 
CV = 4.5% 
Handgrip strength (H) II Good Strength, IGS01 (Metitur Oy, 
Jyväskylä, Finland). A modification 
of the method presented by Viitasalo 
et al. 1985 (Sainio et al. 2005) 
ICC = 0.95, n = 265  
(Sainio et al. 2005) 
Medical diseases, clinical 
examination by physician 
I–III Structured and uniform diagnostic 
criteria based on current clinical 
practice (Aromaa and Koskinen 
2004) 
Diseases, self-reported (I) I, III (Aromaa and Koskinen 2004)  
Diseases, clinical examination 
by physician 
IV Good treatment practice as a 
reference (Aromaa et al. 1985; 
Sievers et al. 1985) 
Sensitivity for knee osteoarthritis 
0.94, n = 740 (Heliövaara et al. 1993) 
Confounding variables 
Age I–IV 
Gender I–IV 
Education (I) I–IV (Aromaa et al. 1989;  
Martelin et al. 2004) 
Marital status (I) I 
Smoking (I) I–IV (Aromaa et al. 1989; Uutela 2004) 
Alcohol use (Q) I–IV (Aromaa et al. 1989; Uutela 2004) 
Physical activity (Q) IV (Mälkiä 1983) 
Medication II (Aromaa and Koskinen 2004) 
Notes: H = Measurement performed also in home health examination in the Health 2000 Survey; 
I = Based on interview in the Health 2000 Survey; Q = Based on questionnaire in the Health 2000 
Survey. ICC = intra class correlation; r = correlation coefficient; ? = kappa coefficient; CV = coefficient 
of variation. 
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Walking limitation (outcome measure) 
The main outcome variable in this study was walking limitation defined according to 
walking speed and self-reported walking difficulty. Maximal walking speed was 
measured over a distance of 6.1 meters starting from a standstill (Fiatarone et al. 
1994). Walking aids were allowed if the person normally used them when walking. 
In the home health examination, a shorter distance was allowed in the walking test if 
it was not possible to implement the 6.1 meters course. Participants were considered 
to have walking limitation if their walking speed was less than 1.2 m/s or if they 
were unable to finish the test. For those who did not participate in the walking test, 
self-reported difficulty (major or minor) or inability to walk 500 meters was used to 
indicate walking limitation. Self-reported walking difficulty was assessed in the 
interview by the question: “Are you able to walk about half a kilometer without 
resting?” The four response options were: without difficulty, with minor difficulty, 
with major difficulty and not at all. The number of persons who did not participate 
in the walking test was 235 in Study I, 24 in Study II, 32 in Study III, and 98 in 
Study IV. 
In order to confirm the association between walking speed and self-reported 
difficulty in walking 500 meters, Receiver operator characteristics (ROC) analysis 
was implemented with the sample used in Study I. The accuracy of the walking 
speed test in classifying persons as having or not having difficulties in walking 
500 meters was determined using logistic regression models and reported as the area 
under the ROC curve (AUC). On the basis of the sensitivity and specificity values of 
various walking speed cut-off points shown in Figure 4, the ROC curve was 
generated. The area under the ROC curve was 0.892 indicating that the walking 
speed test predicted self-reported walking difficulties with a high degree of 
accuracy. The greatest diagnostic accuracy (fewest false positives and false 
negatives) was found at the 1.2 m/s cut-off point (sensitivity 79%, specificity 84%), 
which was therefore used as the cut-off point for walking limitation in this study.  
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Figure 4. Receiver operator characteristics (ROC) curve generated from the sensitivity 
and specificity of different cut-off points for walking speed (m/s). Area 
under the ROC curve (AUC) is indicated in the figure.  
Obesity indicators (explanatory variables) 
Body mass index was calculated by dividing body weight (kg) by the height squared 
(m2). The measurement was performed with the participant wearing light indoor 
clothing without shoes, weight was measured to the nearest 100 grams and standing 
height to the nearest 0.5 centimeters. For those who did not attend health 
examinations self-reported body weight and height were used. The need to use self-
reported information on weight and height was infrequent: only 7% (n = 207) in 
study I and less than 1% (n = 18) in study III. In the Health 2000 Survey, BMI was 
considered a categorical variable since the risk of disability associated with BMI is 
not assumed to be linear (Galanos et al. 1994; Mendes de Leon et al. 2006). BMI 
was classified into five categories: underweight (BMI < 18.5 kg/m2), normal weight 
(BMI 18.5–24.9 kg/m2), overweight (BMI 25–29.9 kg/m2), obesity (BMI 30–
34.9 kg/m2), and severe obesity (BMI ? 35 kg/m2) (World Health Organization 
2000). Normal weight was chosen, a priori, as the reference category for the 
multivariate analyses.  
Waist Circumference was measured on the naked skin at the end of a light expiration 
with the person standing, and the result was rounded to the nearest 0.5 centimeter. 
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Because no standard international criteria for waist circumference classification are 
available, in study II waist circumference was divided into gender-specific quartiles. 
The cut-off points for the gender-specific quartiles were 0.925, 0.995, and 1.07 
meters (range 0.72–1.49 m) in men and 0.835, 0.92 and 1.00 meters (range 0.59–
1.62 m) in women. Body fat percentage was measured with eight-polar bioelectrical 
impedance analysis (BIA) (InBody 3.0, Biospace, Seoul, South-Korea). The gender-
specific cut-off points for the body fat percentage quartiles were 20.8, 25.0, and 29.1 
(range 9.3–44.6) in men, and 31.4, 35.6 and 40.0 (range 13.9–56.6) in women. The 
lowest quartiles for waist circumference and body fat percentage were considered 
the reference categories in the analyses. 
Obesity history classification was based on information about current BMI as well as 
BMI at the ages of 20, 30, 40, and 50 years. Past BMIs were calculated according to 
recalled height at the age of 20 and weight at the ages of 20, 30, 40, and 50 years. 
On the basis of previous studies, it was assumed that body height had not changed 
substantially between the age of 20 and 50 years (Stafford et al. 1998; Sorkin et al. 
1999). According to BMI at the given ages, participants were dichotomized into 
non-obese (< 30 kg/m2) and obese (? 30 kg/m2). Furthermore, they were categorized 
according to duration of obesity: 1) never obese, 2) previously obese, but currently 
non-obese, 3) currently obese, but non-obese at the ages of 20–50 years, 4) obese 
since age 50 years, 5) obese since age 40 years, 6) obese since age 30 years. Those 
who had been obese since age 20 years (n = 3) were merged with the last category. 
Persons who were currently obese but non-obese at age 50 years yet obese at age 30 
or 40, years were excluded from the analyses (n = 11).  
Physical impairments (explanatory variables) 
In study IV, a set of physical impairments was determined to indicate early 
predictors of walking limitation in later life. Handgrip strength, as an indicator of 
overall muscle strength (Rantanen et al. 1994), was measured in kiloponds (kp) 
using a hand-held dynamometer (Bruel-Kjaer Type 1526, Denmark) (Mälkiä 1983). 
One kilopond corresponds to a weight of one kilogram. Measurement was done in 
seated position with the elbow flexed at an angle of 110°–140° and the width of the 
handle was adjusted for the subject’s handsize. The best result of the stronger hand 
was used in the analyses. The cut-off points for the gender-specific handgrip 
strength tertiles were 50 and 58 kiloponds in men (range 15–87 kp) and 27 and 33 
kiloponds in women (range 9–52 kp). The lowest tertile is referred to as impaired 
strength. General fitness was examined by the question: “Can you run a longer 
distance (about 500 meters)?” The four response categories were: without difficulty, 
with minor difficulty, with major difficulty, or not at all. The last two categories 
were combined to represent impaired fitness in middle-aged individuals. Lower limb 
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performance was assessed by a squatting test (Sievers et al. 1985). Participants were 
asked to squat and stand up once. They were allowed gently to take support from a 
table to keep their balance. A trained nurse observed and evaluated the performance: 
normal (thighs at least on the horizontal level), impaired (thighs above horizontal 
level, but an angle of lean more than 45°) or unable (thigh angle of lean less than 
45°). For this study, the categories impaired and unable were merged to indicate 
impaired squatting in middle-aged persons.  
Mediating and confounding factors 
In the Health 2000 Survey, handgrip strength was measured in Newtons (N) in the 
dominating hand using a hand-held dynamometer (Good Strength, IGS01, Metitur 
Oy, Jyväskylä, Finland) (Sainio et al. 2005). Measurement was performed with the 
person in the seated position, elbow flexed at an angle of 110°, wrist in the neutral 
position, and the interphalangeal joint of the index finger an angle of 90°. The cut-
off points for the gender-specific quartiles were 334, 407, and 476 Newton (range 
73–760 N) in men and 168, 221 and 269 Newton (range 13–525 N) in women 
(Study II). Blood samples for sensitive C-reactive protein (CRP) determination were 
drawn during the clinical examination after fasting for four hours. The cut-off points 
for the CRP quartiles were 0.41, 1.09, and 2.72 mg/l (range 0.10–191 mg/l) (Study 
II).
In the Health 2000 Survey (Studies I–III), a specially trained physician ascertained 
the medical conditions of those persons who attended the study center health 
examination by using structured, uniform diagnostic criteria based on current 
clinical practice. For those who did not attend the health examination, a self-report 
of diseases diagnosed by a physician was used, based on answers to the question: 
“Has a doctor ever told you that you have…?”, followed for a list of 42 separate 
medical conditions. In addition, anti-inflammatory drugs and estrogen replacement 
therapy during the preceding 7 days was determined by checking the names of drugs  
from the package or prescription (Pradhan et al. 2002; Prasad 2006) (Study II). At 
the baseline of the Mini-Finland Follow-up Survey (Study IV), specially trained 
physicians ascertained the presence of chronic conditions in a clinical examination 
by combining the results of measurements and biochemical analyses with 
information gathered from interviews and questionnaires, using current good 
treatment practice as a reference (Aromaa et al. 1985; Sievers et al. 1985).  
The sociodemographic variables used in the present series of studies were gender, 
age, education, and marital status. Smoking and alcohol use were elicited in 
interviews and questionnaires as indicators of health behavior. In addition in study 
IV, level of habitual leisure time physical activity was used. Accordingly, 
39
participants were classified as regular physical exercise (e.g. running, biking, 
gymnastics), occasional physical exercise or physically active hobbies (e.g. 
gardening, hunting, outdoor recreations), and little physical exercise (e.g. reading, 
watching television).  
The above-mentioned covariates have been shown to be related to obesity and 
walking limitation (Stuck et al. 1999; Bootsma-van der Wiel et al. 2002) and were 
thus considered to be potential mediators or confounders in the association between 
obesity and walking limitation. Associations between these variables and walking 
limitation or obesity indicators were checked before the analyses. In addition to 
mediating and confounding factors, some variables may moderate the way in which 
obesity and walking limitation are related. In this study, age, gender, chronic 
diseases, CRP, and handgrip strength were considered to be potential effect-
modifiers of the association between obesity and walking limitation and the 
interaction effects of these variables and obesity on walking limitation were tested. 
4.3 Statistical methods 
This is an observational study on the association between obesity and walking 
limitation as well as the factors that mediate the association, and it is based on three 
different study designs. Studies I and II are cross-sectional studies on a 
representative sample of the Finnish population aged 55 years or older. Cross-
sectional studies are valuable in studying the associations between variables, but 
they do not contain information about the timing of explanatory and outcome 
variables. Thus, to learn about causal relationships between variables requires a 
longitudinal design. Study IV is a prospective study with a 22-year follow-up. Long-
term prospective studies are especially important in gerontological research as they 
enable the age-related changes in various health indicators to be explored. With 
prospective studies it is also possible to recognize factors that increase or decrease 
the risk of later life adverse health outcomes such as functional limitation, disability, 
diseases, and death. Study III is a retrospective study which includes information 
about the participants’ weights since the age of 20 years. Although retrospective 
studies based on recalled information provide less reliable information about the 
explanatory variables than prospective studies, they nevertheless have the power to 
establish the causal order of predictors and outcomes. 
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In this study, age- and gender-adjusted prevalence or incidence of walking limitation 
in different obesity categories was calculated using logistic regression models. The 
linearity of the association between the obesity indicators and walking limitation 
was tested either with the Cochran-Armitage Trend test (Study I) or with the 
generalized linear model (GLM) procedure of the SAS statistical package (Studies 
II–IV). In study III, differences in the prevalence of walking limitation between 
gender and the obesity history categories were calculated with Cochran-Mantel-
Haenszel tests. The interaction effects of gender*obesity indicators and age*obesity 
indicators on walking limitation were also tested (surveylogistic). Only in study I a 
statistically significant interaction was found between gender and BMI (p = 0.03), 
and therefore in that study the analyses were conducted separately for men and 
women. The normality of the distribution of continuous variables like BMI, waist 
circumference, body fat percentage, walking speed, handgrip strength, and CRP was 
tested with the Kolmogorov-Smirnov test. Due to the skewed distribution of CRP 
values, the analyses concerning continuous CRP were performed using its log 
values. 
With respect to walking limitation as a dichotomous dependent variable, logistic 
regression models were used to analyze its association with the different obesity 
indicators. The results were presented as Odds Ratios (OR) with 95% confidence 
intervals (CI). In each study, a hierarchical set of logistic regression models was 
constructed, and the age- and gender-adjusted model served as the base model (in 
study I the base model was age-adjusted). The chosen covariates were then adjusted 
sequentially in logical groups, including sociodemographic factors (education and 
marital status), health behavioral factors (smoking, alcohol use and physical 
activity), medical conditions and biological indicators (CRP and handgrip strength). 
The models in which handgrip strength was included were also adjusted for body 
height, since handgrip strength is known to correlate strongly with body size 
(Rantanen et al. 1998b). 
The reference categories for the obesity indicators were normal weight for BMI, 
never obese for obesity history, and the lowest quartile for waist circumference and 
body fat percentage. In study IV, in addition to the obesity indicators the 
independent variables included handgrip strength, running, and squatting. The 
reference categories for the 500 meters running and squatting test were “no 
difficulties” and “normal”. The association of BMI, as well as handgrip strength, 
with walking limitation was found to be linear (tested with SAS-GLM procedure). 
BMI and handgrip strength were therefore used as continuous variables in the 
logistic regression models. In studies I and II, the individual effect of each covariate 
on the association between the obesity indicators (BMI, waist circumference, body 
fat percentage) and walking limitation was examined by adding the covariates one at 
a time into the age- and gender-adjusted model. The percentage reduction in ORs 
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was then calculated as in previous studies (Lynch et al. 1996; Stronks et al. 1996; 
Laaksonen et al. 2005): 
Calculations were performed only for those categories of obesity indicators that 
were statistically significantly associated with walking limitation in the age- and 
gender-adjusted model. 
The associations between the potential covariates and walking limitation as well as 
potential covariates and obesity indicators were examined separately in each study. 
All the variables that were associated with walking limitation (p < 0.05) and linearly 
with obesity indicators (p < 0.10) were included in the logistic regression models as 
covariates. The association of covariates with walking limitation was tested with the 
?2-test or the Fisher exact test. For the continuous obesity indicators (BMI, waist 
circumference and body fat percentage) logistic regression models (Wald test) and 
for the categorical obesity indicator (obesity history) the SAS-GLM procedure was 
used to compare levels of covariates across levels of obesity indicators. 
The effect of coimpairment and comorbidity on walking limitation was studied with 
logistic regression models by categorizing the subjects into six (study IV) and nine 
(study II) groups according to BMI and diseases, BMI and physical impairments 
(study IV) and body fat percentage and CRP and handgrip strength (study II), 
respectively. The interaction effects of BMI*diseases, BMI*physical impairments, 
fat percentage*CRP and fat percentage*handgrip strength on walking limitation 
were studied with the SAS-GLM procedure.  
Statistical analyses were completed using SAS software version 9.1 (SAS Institute 
Inc., Cary, NC). For the analyses, the data were weighted to reduce the bias due to 
non-response and to correct for the over-sampling in the age group of 80 years and 
older. The complex sampling design was taken into account by using SUDAAN 
procedures version 9.0 (SUDAAN Language Manual, Research Triangle, NC). The 
numbers of subjects slightly differ for each analysis, as cases with missing values for 
specific covariates were excluded from the corresponding analyses.  
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5 RESULTS
5.1 The characteristics of the study populations 
The characteristics of the participants in the Health 2000 Survey as well as in the 
Mini-Finland Follow-up Survey are summarized in Table 3. In the Health 2000 
Survey, 23% of the participants were 55–59 years old, 37% were 60–69 years old, 
28% were 70–79 years old, and 12% were 80 years or older. Age ranged from 55 to 
99 year. The majority of the participants were women (57% vs. 43%). Women were 
older and had higher BMI and lower hand grip strength than men (p < 0.0001). 
Chronic diseases were relatively common among the participants. Hypertension 
(men 32% vs. women 38%, p = 0.001), coronary heart disease (men 21% vs. women 
16%, p < 0.0001), and knee osteoarthritis (men 11% vs. women 18%, p < 0.0001) 
were the most prevalent conditions. Furthermore, women were more often 
physically sedentary, smoked less and used alcohol less than men (p < 0.0001). At 
the baseline of the Mini-Finland Follow-up Survey, 29% of the persons were 
younger than 40 years, 40% were 40–49 years old, 24% were 50–59 years old, and 
8% were 60 years or older. Age ranged from 32 to 72 years. Mean BMI was 25.1 
kg/m2 in men and 24.4 kg/m2 in women (p = 0.001). The prevalence of chronic 
diseases was relatively low. Men had pulmonary disease more often than women 
(12% vs. 7%, p = 0.013) and women had knee osteoarthritis more often than men 
(6% vs. 2%, p = 0.005). Women were physically more inactive than men (p = 0.03), 
but men smoked and used alcohol more than women (p < 0.0001). 
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Table 3. Characteristics of the participants in the Health 2000 Survey and the  
Mini-Finland Follow-up Survey 
 Health 2000 Survey  
Mini-Finland
Follow-up Survey* 
 n = 2 961  n = 840 
Characteristic Mean (SD)  Mean (SD) 
Age, years 67.5 (8.8)  45.8 (8.7) 
Body Mass Index, kg/m2 27.8 (4.4)  25.0 (3.5) 
Handgrip strength† 306.6 (122.7)  39.8 (14.9) 
 %  % 
Women 57.2  56.9 
Walking limitation 32.8  0 
Coronary heart disease 18.1  3.3 
Hypertension 35.4  8.6 
Pulmonary disease 11.0  8.8 
Type 2 diabetes 9.4  1.3 
Knee osteoarthritis 15.1  4.2 
Hip osteoarthritis 10.0  0.8 
Physical inactivity 29.2  20.8 
Smoking behavior    
Never smoker 59.6  54.1
Former smoker 25.4  24.1
Current smoker 15.0  21.9
Alcohol use    
Not at all 48.1  27.9
Moderate use 47.1  62.0
Heavy use 4.8  10.1
Education    
Higher (? 13 years) 19.6  17.3
Intermediate (10–12 years) 47.5  36.9
Basic (< 10 years) 32.9  45.8
Notes: *Baseline characteristics. †Handgrip strength was measured in the Health 2000 Survey in 
Newtons and in the Mini-Finland Follow-up Survey in kiloponds. In the table means and standard 
deviations (SDs) for the continuous variables, and percentages for the categorical variables are 
presented.
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5.2 Prevalence of walking limitation by obesity indicators (I–III) 
In the Health 2000 Survey, the overall prevalence of walking limitation among 
persons aged 55 years or over was 32%. When adjusted for age, walking limitation 
was more common among women (36%) than men (27%) (p < 0.0001). When 
adjusted for gender walking limitation increased linearly with increasing age from 
12% among the 55- to 59-year-olds, to 20% among the 60- to 69-year-olds, 46% 
among the 70- to 79-year-olds and to 81% among persons who were 80 years or 
older (p for linear trend < 0.0001). Table 4 shows the age- and gender-adjusted 
prevalence of walking limitation according to the different obesity indicators. 
Within each obesity indicator a gender difference was observed, women having a 
significantly higher prevalence of walking limitation than men at the same level of 
obesity (p < 0.0001). The only statistically significant interaction between gender 
and obesity indicators on walking limitation was observed for BMI (p = 0.03).  
In women, the prevalence of walking limitation increased linearly with increasing 
BMI from the normal weight category (BMI 18.5–24.9 kg/m2) to the severely obese 
category (BMI ? 35 kg/m2). In men the trend was also significant, but the prevalence 
increased steeply among those who were severely obese. As in the case of BMI, 
waist circumference, body fat percentage, and obesity history were linearly 
associated with walking limitation (p for linear trend < 0.0001). When all the 
potential covariates were taken into account, individuals with high BMI (? 35 kg/m2
in men and ? 30 kg/m2 in women), large waist circumference (> 0.995 m in men, 
> 0.92 m in women), and a high percentage of body fat (> 25% in men, > 36% in 
women), had statistically significantly increased risk of walking limitation. 
The correlations between BMI, waist circumference, and body fat percentage were 
moderate to high. BMI show a high correlation with waist circumference (r = 0.90 in 
men and r = 0.85 in women) and moderate with body fat percentage (r = 0.75 in men 
and r = 0.86 in women). In addition, waist circumference and body fat percentage 
show a moderate correlation (r = 0.73 in men and r = 0.78 in women). Among 
persons classified as obese according to BMI, 95% were in the two highest quartiles 
for waist circumference (> 0.995 m in men, > 0.92 m in women) and 93% were in 
the two highest quartiles for body fat percentage (> 25% in men, > 36% in women). 
78% of persons who were in the two highest quartiles for waist circumference were 
also in the two highest quartiles for body fat percentage.  
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Table 4. Prevalence of walking limitation by obesity indicators and gender in the 
Health 2000 Survey 
 Men 1  Women 1  Total 1,2
Body mass index (kg/m2) n = 1 158 %  n = 1 737 %  n = 2 895 % 
< 18.5 5 26.4  29 37.5  34 32.7 
18.5–24.9 336 22.1  512 31.3  848 27.5 
25–29.9 540 21.7  686 34.8  1226 29.3 
30–34.9 233 29.4  378 45.1  611 38.7 
? 35 44 47.3  132 58.3  176 53.5 
p for linear trend†  **   ***   *** 
p for gender difference   ***      
p for gender*BMI interaction   *      
Waist circumference (m) n = 1 067 %  n = 1 565 %  n = 2 632 % 
I M: 0.72–0.925 W: 0.59–0.835  253 20.6  390 29.7  643 25.8 
II M: 0.93–0.995 W: 0.84–0.92  281 16.8  404 30.6  685 24.8 
III M: 1.00–1.07  W: 0.925–1.00 265 23.5  372 36.5  637 31.2 
IV M: 1.075–1.49  W: 1.005–1.62 268 33.2  399 50.7  667 43.5 
p for linear trend  ***   ***   *** 
p for gender difference   ***      
p for gender*waist  
circumference interaction 0.602
    
Body fat percentage (%) n = 905 %  n = 1 219 %  n = 2 124 % 
I M: 9.3–20.8  W: 13.9–31.4 224 8.4  295 23.2  519 16.5 
II M: 20.9–25.0 W: 31.5–35.6 222 15.3  303 21.0  525 18.1 
III M: 25.1–29.1 W: 35.7–40.0 229 16.8  312 32.1  541 25.3 
IV  M: 29.2–44.6 W: 40.1–56.6 230 31.5  309 45.5  539 39.1 
p for linear trend  ***   ***   *** 
p for gender difference   ***      
p for gender*body fat 
percentage interaction 0.100
    
Continued overleaf 
46
Table 4 continued 
 Men 1  Women 1  Total 1,2
Obesity history n = 877 %  n = 1 157 %  n = 2 034 % 
Never obese 612 15.2  748 22.7  1360 19.3 
Previously obese, currently  
non-obese 39 26.3  32 47.5  71 36.8 
Currently obese, but  
non-obese at ages 20–50 151 23.9  285 37.0  436 31.2 
Obese since age 50 years 47 26.3  67 53.7  114 42.5 
Obese since age 40 years 18 36.5  21 59.0  39 49.0 
Obese since age 30 years 10 44.5  4 69.6  14 56.9 
p for linear trend ‡  *   **   *** 
p for gender difference  ***     
p for gender*obesity history 
 interaction 0.603
Notes: The data in this table are limited to subjects who had not lost unintentionally more than 5 kg in 
weight during the previous 12 months. 1Adjusted for age. 2Adjusted for gender. †Underweight persons 
were not included in the linearity analysis. ‡Previously obese, but currently non-obese persons were not 
included in the linearity analysis. *** p < 0.0001, ** p < 0.01, * p < 0.05. 
5.3 Mediating factors between obesity and walking limitation (I, II) 
In order to study the mediating role of obesity-related diseases between high BMI 
and walking limitation, sequential logistic regression analyses were performed. The 
age-adjusted models indicated that the risk of walking limitation was statistically 
significantly increased among obese and severely obese men, and in overweight, 
obese, and severely obese women (Table 5). After adjusting for education, marital 
status and smoking, the ORs in men remained rather similar (7% decrease in OR 
among severely obese men), and were attenuated somewhat more in women (14% in 
overweight, 15% in obese, and 19% in severely obese). Adjusting further for chronic 
diseases substantially reduced the ORs in men (60% in obese and 46% in severely 
obese) and women (40% in overweight, 45% in obese, and 45% in severely obese). 
However, the excess risk of walking limitation remained statistically significant in 
severely obese men (OR 2.78, 95% CI 1.30–2.78), and in obese (OR 1.97, 
95% CI 1.38–2.81) and severely obese women (OR 3.64, 95% CI 2.12–6.26). Of all 
the chronic diseases, type 2 diabetes in men (32%) and knee osteoarthritis in women 
(18%) contributed most to the association between high BMI and walking limitation, 
followed by hypertension in men (14%) and angina pectoris in women (8%). The 
changes in the log likelihood scores indicate that the adjusted variables contributed 
slightly more to the association between BMI and walking limitation in men than in 
women.
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Table 5. The risk of walking limitation in different body mass index categories and 
the effect of mediating factors for men and for women 
 Men  Women 
 Model 1 Model 2 Model 3  Model 1 Model 2 Model 3 
OR
(95% CI) 
OR
(95% CI) 
OR
(95% CI) 
OR
(95% CI) 
OR
(95% CI) 
OR
(95% CI) 
Body mass index        
18.5–24.9 1.00 1.00 1.00  1.00 1.00 1.00 
25–29.9 0.97  (0.66–1.42) 
1.05  
(0.71–1.57) 
0.91  
(0.60–1.37)
1.47  
(1.10–1.96) 
1.40  
(1.03–1.91) 
1.28  
(0.93–1.76) 
30–34.9 1.63  (1.04–2.55) 
1.65  
(1.03–2.65) 
1.25  
(0.76–2.05)
2.77  
(2.01–3.82) 
2.50  
(1.80–3.49) 
1.97  
(1.38–2.81) 
? 35 4.33  (2.20–8.53) 
4.10  
(2.01–8.38) 
2.78  
(1.30–5.95)
5.80  
(3.52–9.54) 
4.91  
(2.95–8.15) 
3.64  
(2.12–6.26) 
        
Age, years 1.13  (1.11–1.16) 
1.12  
(1.10–1.15) 
1.11  
(1.08–1.14)
1.16  
(1.14–1.17) 
1.14  
(1.13–1.16) 
1.12  
(1.10–1.14) 
Education        
Basic 3.62  (2.00–6.55) 
3.13  
(1.68–5.84)
2.92  
(2.01–4.23) 
2.63  
(1.80–3.86) 
Intermediate  2.18  (1.26–3.78) 
1.98  
(1.10–3.58)
1.99  
(1.38–2.87) 
1.80  
(1.22–2.65) 
Higher  1.00 1.00   1.00 1.00 
Living alone*  2.12  (1.47–3.06) 
2.45  
(1.67–3.59)
1.38  
(1.10–1.75) 
1.38  
(1.08–1.77) 
Current smoking† 1.65  (1.14–2.40) 
1.64  
(1.11–2.40)
1.47  
(1.08–2.00) 
1.54  
(1.11–2.13) 
        
Angina pectoris   1.24  (0.84–1.84)    
1.89  
(1.36–2.62) 
Heart failure   3.02  (1.54–5.92)    
2.22  
(1.26–3.93) 
Hypertension   1.38  (0.96–1.99)    
1.14  
(0.88–1.48) 
Type 2 diabetes   2.78  (1.72–4.50)    
1.52  
(0.97–2.39) 
Knee osteoarthritis   1.67  (1.02–2.74)    
1.87  
(1.37–2.55) 
Hip osteoarthritis   2.28  (1.39–3.71)    
2.18  
(1.36–3.49) 
-2 Log L 1052.63 991.67 932.21  1560.41 1511.43 1438.28 
Notes: Model 1: adjusted for age; Model 2: Model 1 + adjustment for education, marital status, and smoking; 
Model 3: Model 2 + adjustment for angina pectoris, heart failure, hypertension, type 2 diabetes, knee and hip 
osteoarthritis. *Reference for living alone (divorced, separated, widowed, or single) is married or cohabiting. 
†Reference for current smoking is non-smoking (never or ex-smoker). OR = odds ratio; CI = confidence 
interval; -2 Log L = Log likelihood score indicates model fit. 
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By limiting the study population to those persons, who participated in the health 
examination, it was possible to conduct a more detailed analysis on the potential 
mediators between obesity and walking limitation. In addition to chronic diseases, 
the mediating role of biological indicators, CRP and handgrip strength, known to be 
associated with obesity and functional limitation, were studied. First, the 
independent associations between BMI, waist circumference, and body fat 
percentage, CRP, handgrip strength, and walking speed were studied with linear 
regression analyses. After adjustment for potential confounders (age, gender, 
education, smoking, alcohol use, coronary heart disease, hypertension, pulmonary 
disease, type 2 diabetes, arthritic disease, anti-inflammatory drugs and estrogen use), 
high BMI, high waist circumference, and high body fat percentage were positively 
associated with higher CRP (p for all < 0.0001). Moreover, negative and statistically 
significant associations were found between CRP and handgrip strength (p = 0.001) 
and CRP and walking speed (p < 0.0001). In addition, handgrip strength was 
positively associated with walking speed (p < 0.0001). 
Logistic regression analysis was used to study the mediating factors between body 
fat percentage and walking limitation (Figure 5). After controlling for education, 
health behavioral factors (smoking and alcohol use), several chronic diseases 
(coronary heart disease, hypertension, pulmonary disease, type 2 diabetes, and joint 
disease), and use of anti-inflammatory drugs and estrogen, the ORs for the lowest to 
the highest body fat percentage quartiles were 1.0 (reference), 1.20 (95% CI 0.78–
1.83), 1.80 (95% CI 1.23–2.67), and 3.10 (95% CI 2.13–4.52), respectively. Further 
adjustment for CRP attenuated greatly the ORs in body fat percentage quartiles III 
and IV. Finally, adjusting additionally for handgrip strength and body height 
reduced further the effect of fat percentage on walking limitation. In the final model, 
the excess prevalence of walking limitation in the two highest quartiles for body fat 
percentage remained statistically significant, the ORs being 1.64 (95% CI 1.11–
2.44) and 2.53 (95% CI 1.70–3.77), respectively. In the gender-specific analyses, 
CRP and handgrip strength attenuated the association between body fat percentage 
and walking limitation more in women than in men. The respective percentage 
reductions in women and men were 30% and 17% for CRP and 15% and 7% for 
handgrip strength. There was a significant interaction effect of gender*handgrip 
strength on walking limitation in the two highest quartiles for body fat percentage 
(p = 0.04 and p = 0.02). 
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Figure 5. Effects of different groups of mediators on the risk of walking limitation in 
body fat percentage quartiles.  
5.4 Long-term risk of walking limitation in relation to obesity and 
physical impairments (III, IV) 
In a retrospective longitudinal study, in addition to current obesity, early onset of 
obesity and obesity duration were found to increase the risk of walking limitation. 
An increasing gradient in the age- and gender-adjusted risk of walking limitation 
from never obese, through currently obese, to obese since age 50, 40, and age 30 
years was found (p for linear trend < 0.0001) and the corresponding ORs and 
95% CIs were 1.00, 2.29 (1.70–3.09), 4.33 (2.59–7.23), 6.01 (2.55–14.14), and 
8.97 (3.06–26.29). The risk of walking limitation was also significantly higher 
among those who were currently non-obese but had previously been obese (OR 
3.15, 95% CI 1.63–6.11). This was the only obesity history category where the 
increased risk of walking limitation did not remain statistically significant after 
adjusting for education, life style factors and chronic diseases. The impact of chronic 
diseases was particularly prominent in this group of previously obese but currently 
non-obese persons, largely explaining the high risk of walking limitation. 
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A negative effect of midlife obesity on walking limitation was found in the Mini-
Finland Follow-up Survey, where persons were followed for 22 years. Among the 
840 persons who did not initially have walking limitation, walking limitation 
developed over the 22-year follow-up in 176 subjects. The age-adjusted incidence of 
walking limitation was higher among women (25%) than men (16%) (p < 0.0001). 
The prevalence of obesity in 1978–1980 was relatively low (5.2% in men and 11.1% 
in women), but the age- and gender-adjusted risk of later life walking limitation was 
higher among initially obese persons (OR 3.57, 95% CI 1.93–6.62) compared with 
normal weight persons. Furthermore, the risk of later life walking limitation per 
standard deviation (SD) increase in BMI was significant (OR 1.39, 95% CI 1.10–
1.75) after adjustment for baseline confounders (age, gender, education, physical 
activity, alcohol use, smoking, angina pectoris, heart failure, hypertension, chronic 
bronchitis, diabetes, low back syndrome, and knee osteoarthritis). In addition to 
obesity, physical impairments (low handgrip strength, running and squatting 
difficulties) in middle age predicted later life walking limitation, and the 
associations remained significant after adjusting for baseline confounders. The 
adjusted risk of walking limitation was 2.4-fold among those who had major running 
difficulties and 4.6-fold among those who had squatting difficulties compared with 
those who had no difficulties. The corresponding OR for handgrip strength was 0.56 
(95% CI 0.38–0.81) per an increment of one SD. 
5.5 The effect of coimpairment and comorbidity on walking 
limitation (I, II, IV) 
At the baseline of the Mini-Finland Follow-up Survey, the prevalence of diseases 
was relatively low. Therefore the effect of coimpairment, instead of comorbidity, on 
later life walking limitation was studied. Coimpairment was defined according to the 
combination of overweight and physical impairments, and altogether six categories 
were produced (Figure 6). The age- and gender-adjusted risk of walking limitation 
was over six times higher among those who were overweight (highest BMI tertile) 
and had two or more physical impairments as compared with those who were neither 
overweight nor had impairments (OR 6.35, 95% CI 2.82–14.33). Also those subjects 
who were not overweight but had two or more physical impairments had an over 
five-fold higher risk of walking limitation (OR 5.42, 95% CI 2.57–11.42). No 
interaction effect of overweight*number of physical impairments on walking 
limitation was found. 
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Figure 6. Age- and gender-adjusted risk of walking limitation according to number of 
physical impairments with or without coexisting overweight at baseline. 
Overweight is defined as the highest BMI tertile. 
In the Health 2000 Survey, the effect of comorbidity on walking limitation was 
evaluated by categorizing subjects into six categories according to their obesity and 
disease status (Figure 7). The age- and gender-adjusted risk of walking limitation 
was over 6.5 times higher among those who were obese (BMI ? 30 kg/m2) and had 
two or more diseases as compared with those who neither were obese nor had 
diseases (OR 6.51, 95% CI 4.76–8.90). Also those subjects who were not obese but 
had two or more diseases had an over three-fold higher risk of walking limitation 
(OR 3.22, 95% CI 2.48–4.18). No interaction effect of obesity*number of diseases 
on walking limitation was found. 
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Figure 7. Age- and gender-adjusted risk of walking limitation according to number of 
diseases with or without coexisting obesity. Obesity is defined as BMI ? 30 
kg/m2.
Finally, the cross-sectional data were used to identify the most vulnerable persons in 
terms of obesity and handgrip strength and to study the effect of the combination of 
high body fat percentage and low handgrip strength on walking limitation. A clear 
gradient of increased prevalence of walking limitation with decreasing handgrip 
strength was found within all three body fat percentage categories (Figure 8). 
Among those with both low handgrip strength and high body fat percentage, the 
prevalence of walking limitation was 61%, whereas in the group with high handgrip 
strength and low body fat percentage only 7% had walking limitation. No interaction 
effect of fat percentage*handgrip strength on walking limitation was found. 
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Figure 8. The age- and gender-adjusted prevalence of walking limitation according to 
body fat percentage levels and handgrip strength. Low, medium and high 
levels of fat percentage and handgrip strength were defined by combining 
quartiles II and III. Numbers inside the bars indicate the number of persons 
in each category. 
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6 DISCUSSION 
In this study of a representative population-based sample of Finnish men and women 
aged 55 years or older, overweight and obesity were found to be independently 
associated with walking limitation, more strongly in women than in men. The 
factors that contributed most to the association between BMI and walking limitation 
were type 2 diabetes in men and knee osteoarthritis in women. In addition, adjusting 
for CRP and handgrip strength attenuated the association between high body fat 
percentage and walking limitation. This study also showed that high BMI measured 
in middle age predicted walking limitation 22 years later. Similarly, simple tests of 
physical impairments were found to be predictive of later life walking limitation. In 
addition to midlife obesity, duration of obesity over several decades also increased 
the risk of walking limitation. Finally, the present study demonstrated that 
overweight or obese persons with coexisting diseases or physical impairments 
comprise a high risk group with regard to current or future walking limitation 
compared with only overweight or obese persons, indicating that comorbidity and 
coimpairment have a negative effect on physical functioning.  
6.1 Obesity and walking limitation: mediating factors, long-term 
risk and coexisting conditions 
Association between different obesity indicators and walking limitation 
Consistent with previous cross-sectional population-based studies, high BMI 
(Coakley et al. 1998; Davison et al. 2002; Larrieu et al. 2004; Ramsay et al. 2006), 
large waist circumference (Ramsay et al. 2006), and high body fat percentage 
(Visser et al. 1998a; Visser et al. 1998b; Broadwin et al. 2001; Sternfeld et al. 2002; 
Ramsay et al. 2006) were all found to be strongly associated with an increased 
prevalence of walking limitation after controlling for medical conditions and several 
other covariates. Only one other study was found in which these three obesity 
indicators have been studied simultaneously as determinants of walking limitation 
and compared with each other (Ramsay et al. 2006). In their study of older British 
men, Ramsay et al. (2006) compared obesity indicators and their association with 
walking limitation with ROC analyses, and found that the areas under the curve 
were similar for BMI, waist circumference, and body fat mass index. Their finding  
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is in accordance with the results of the present study showing that BMI, waist 
circumference and body fat percentage all identify persons at risk of walking 
limitation. 
However, the differences between BMI, waist circumference, and body fat mass as 
measures of obesity in older adults deserve to be discussed. In health-related 
research, BMI is a more commonly used measure of obesity than waist 
circumference or body fat percentage, and it has well-established and internationally 
accepted cut-off points (World Health Organization 2000; Zamboni et al. 2005). 
Although BMI is a good indicator of general obesity, it does not give information 
about fat distribution and does not differentiate between fat and muscle mass. 
Consequently, it may underestimate adiposity among older persons who, because of 
age-related loss in lean body mass, have a greater amount of body fat than younger 
people with a similar BMI (Prentice and Jebb 2001). In addition to changes in body 
composition, age-related decline in body height may modify BMI (Sorkin et al. 
1999). Thus, aging has an increasing influence on the numerator and decreasing 
influence on the denominator of BMI (Zamboni et al. 2005).  
Waist circumference, in turn, is a surrogate of abdominal obesity and strongly 
associated with visceral fat when measured with MRI (Stewart et al. 2003). 
Although body fat percentage and other indicators of body fatness can be measured 
objectively with BIA, DXA, CT or other sophisticated measures, they are not a 
realistic means of identifying at risk individuals in routine primary health care. 
Therefore, to achieve reliable information about obesity in older persons, it has been 
suggested that waist circumference could be used as a complementary measurement 
in addition to BMI (Zamboni et al. 2005). Waist circumference may be particularly 
useful when a reliable measure of weight and height for making BMI calculations 
cannot be obtained. However, interpreting waist circumference values is not an 
unequivocal in older persons. Due to loss of height and kyphotic stature, there is a 
decrease in the vertical space of the abdominal cavity and the diaphragm moves 
downwards causing waist circumference to increase.  
Mediating factors between obesity and walking limitation 
Relatively little research has been performed to explain the possible mediators 
between obesity and walking limitation including sociodemographic and health 
behavioral factors, chronic diseases and biological indicators. According to this 
study, the association between obesity and walking limitation was more pronounced 
in women than in men, an increased risk being observed for overweight women, 
whereas in men only obesity and severe obesity were significantly associated with 
walking limitation. This gender difference has also been found in other studies based 
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on self-reported mobility limitation or disability (Friedmann et al. 2001; Davison et 
al. 2002; Larrieu et al. 2004; Angleman et al. 2006). Friedmann and coworkers 
(2001) have discussed potential explanations for the gender difference, such as 
differences in disabling conditions and differences in reporting physical discomfort 
(Merrill et al. 1997). An additional explanation may relate to body composition. 
Women have more fat as well as lower absolute and relative muscle strength than 
men (Visser et al. 2002a; Lafortuna et al. 2005), and thus they may have more 
difficulties in bearing their excess weight and in moving efficiently. Women, 
compared to men, also more commonly have lower aerobic capacity (Fleg et al. 
2005) and they are physically less active (DiPietro 2001), thus predisposing older 
obese women, in particularly, to walking limitation. Finally, the gender difference in 
survival may have its own effect on the association in question (Jensen 2005), as 
obese men may die before to emerging functional limitation, whereas women are 
known to live longer with functional limitations and disabilities (Leveille et al. 
2000). 
In addition to gender differences in the association between obesity and walking 
limitation, the results of this study suggest that different diseases may mediate the 
effect of obesity on walking limitation. In men, the strong role of type 2 diabetes is 
probably due to the fact that in the older obese population type 2 diabetes is more 
prevalent among men than among women (Must et al. 1999). The potential 
pathways through which diabetes may affect walking limitation include diabetes-
related complications such as sensory-motor neuropathy, peripheral vascular 
disease, and visual impairment (Nathan 1993; Al Snih et al. 2005). In addition, 
insulin resistance may have a negative effect on walking through decline in muscle 
mass and strength (Abbatecola et al. 2005; Guillet and Boirie 2005). The relatively 
strong effect of knee osteoarthritis on walking limitation among overweight or obese 
women found in this study may reflect the fact that excess body weight causes 
mechanical stress on the patellofemoral joint, and the consequent pain and impaired 
muscle strength predispose women to walking limitation (Ling et al. 2003; Messier 
et al. 2005). In addition, female gender and overweight are both strong risk factors 
for knee osteoarthritis (Felson et al. 2000). Osteoarthritis, in turn, is a risk factor for 
mobility limitation (Clark and Mungai 1997; Ling et al. 2003).  
The present study is among the first to examine obesity, CRP, handgrip strength, and 
walking limitation simultaneously, thereby allowing more detailed examination of 
the complex mechanisms around obesity and walking limitation. The results suggest 
that in addition to obesity-related diseases, low-grade inflammation through 
cytokine production in adipose tissue and decreased muscle strength due to 
accelerated catabolism in muscle may partially explain the pathway from obesity to 
walking limitation. Although no other corresponding studies are available, some 
recent studies have investigated the associations between obesity, inflammatory 
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markers, muscle mass or strength (Pedersen et al. 2003; Cesari et al. 2005b; 
Schrager et al. 2007), and frailty (Blaum et al. 2005). In studies related to muscle 
mass and strength, inflammatory markers were found to be positively associated 
with obesity and negatively with high lean body mass or muscle strength, supporting 
the findings of the present study. In contrast, in a study of older women, CRP was 
not found to be associated with frailty among obese persons (Blaum et al. 2005). 
However, it needs to be emphasized that although CRP was found to be a significant 
explanatory factor between high body fat percentage and walking limitation in this 
study, CRP itself may not be the biologically relevant molecule mediating the effect 
of obesity on walking limitation. Rather, CRP may serve as a marker for the 
upregulation of the inflammation pathway and other inflammatory markers such as 
TNF-? and IL-6. Several studies have shown an association between TNF-? and IL-
6 and decreased muscle strength (Visser et al. 2002b; Schaap et al. 2006) as well as 
mobility limitation (Cesari et al. 2004; Penninx et al. 2004; Figaro et al. 2006).  
In addition to obesity-related low-grade inflammation, muscle strength may decrease 
because of an increased level of fat infiltrated in the muscle, which is common 
among people with high overall body fatness (Ryan and Nicklas 1999). Indeed, there 
is evidence that fat infiltration into muscle is associated with lower muscle strength 
and walking performance (Sipilä and Suominen 1994; Goodpaster et al. 2001; 
Visser et al. 2005), thus supporting the pathway from obesity through decreased 
muscle strength to walking limitation. In concordance with that hypothesis, the 
present study found that persons with a high body fat percentage and low muscle 
strength had a substantially higher risk of walking limitation than either obese or 
weak persons. A few studies on sarcopenic obesity and functional limitation exists, 
and Baumgartner et al. (2000; 2004) have reported similar results. However, the 
combination of high fat percentage and low muscle strength used in this study 
differs slightly from the concept of sarcopenic obesity in which sarcopenia refers to 
low muscle mass. According to present knowledge, in older persons muscle strength 
may be a more important predictor in terms of mobility and physical functional 
capacity than muscle mass (Visser et al. 2000; Visser et al. 2005). Although the loss 
of muscle strength with aging is mainly due to decreased muscle mass, strength is 
often reduced to a greater degree than muscle mass (Goodpaster et al. 2006). This 
indicates that there may be other factors, such as reduced motor unit activation 
(Jakobi and Rice 2002) or reduced muscle quality (Visser et al. 2005) which also 
contribute to the loss of strength. 
A potential mediating factor that was not included in the analyses in studies I and II 
is physical activity. It is known that physical activity is an important determinant of 
physical functional capacity in older persons, and also that physical inactivity and 
obesity are related (Bernstein et al. 2004; Brach et al. 2004b; Di Francesco et al. 
2005). However, in gerontological research the role of physical activity in the 
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association between obesity and walking limitation is complicated, especially if 
studied with cross-sectional data. It is obvious that having walking limitation will 
also reduce physical activity, and therefore studying both of these factors 
simultaneously may introduce bias into the results. In contrast, in a longitudinal 
setting, it is clear that physical activity plays a major role in the vicious circle of 
obesity, muscle strength, and walking limitation. A sedentary lifestyle decreases 
physical performance and also exposes to an increase in adipose tissue. This in turn 
may increase the level of circulating inflammation markers and predispose to several 
diseases, thus decreasing muscle mass and strength, and further impairing walking 
and decreasing physical activity. Physical inactivity is thus closely connected to the 
factors that were identified in the present study as mediators in the association 
between obesity and walking limitation. Although physical activity level was not 
controlled in the cross-sectional studies (I and II), handgrip strength and other 
covariates may have conveyed some of the effects of physical activity on the 
relationship between obesity and walking limitation.  
Physical activity has a crucial role in reversing the above-described negative chain 
of causation. First, physical activity can facilitate weight loss and weight 
maintenance (Fogelholm and Kukkonen-Harjula 2000; Ross and Janssen 2001; 
Jakicic et al. 2003). Second, physical activity has been found to be associated with a 
lower level of inflammatory markers (Reuben et al. 2003; Colbert et al. 2004), to 
improve muscle strength and aerobic capacity (Keysor and Jette 2001; Latham et al. 
2003), and to have positive impact on several diseases such as type 2 diabetes and 
cardiovascular diseases (Hu et al. 2004; Lakka and Laaksonen 2007). Moreover, 
studies examining the combined effect of obesity and physical activity have shown 
that the negative health effects related to obesity can be attenuated by physical 
activity. For example, He and Barker (2004) found that regular exercise significantly 
reduced the risk of developing mobility limitation among obese individuals.  
Long-term risk of obesity and weight loss 
There are few studies on the early risk factors of walking limitation. However, it is 
important to study further this topic in order to recognize persons at risk of adverse 
health outcomes in the future. The present study was among the first to show the 
long-term risks of obesity on later life walking. It was also found that physical 
impairments in middle-aged people predict walking limitation in older age. The 
findings are valuable and confirm the results obtained from earlier studies on the 
effect of obesity (Launer et al. 1994; Ebrahim et al. 2000; Houston et al. 2005b), 
muscle strength (Rantanen et al. 1999b; Rantanen et al. 2000) and certain diseases, 
such as osteoarthritis (Guralnik and Kaplan 1989; Hubert et al. 1993; Ettinger et al. 
1994), back pain (Guralnik and Kaplan 1989) and hypertension (Pinsky et al. 1985; 
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Guralnik and Kaplan 1989; Keil et al. 1989; Lammi et al. 1989), on functional 
capacity. The results of this study further supports the claim that the basis for good 
functional capacity in old age is built earlier in life. Thus, increasing physical fitness 
through physical activity and the promotion of weight loss in overweight middle-
aged persons may prevent mobility limitation and subsequent disability in old age.  
Even modest weight loss among obese people of working age has many positive 
effects on the risk factors for coronary heart disease and type 2 diabetes through 
lowering blood pressure and improving the metabolic profile (National Institutes of 
Health 1998; Ross et al. 2004). In addition, weight loss has been found to alleviate 
pain in people with knee osteoarthritis (Huang et al. 2000; Martin et al. 2001) and 
improve physical function and health-related quality of life (Fine et al. 1999; 
Kaukua et al. 2003). However, weight loss attempts in old age may have adverse 
effects on health and functional capacity. So far, a few studies on the effects of 
intentional weight loss on obese elderly people’s health and functional capacity have 
been published. In those studies, depending on the interventions and outcome 
measures used, conflicting results have been obtained (French et al. 1995; Messier et 
al. 2004; Lee et al. 2005; Messier et al. 2005; Villareal et al. 2006). It has been 
suggested that a supervised weight loss program, which includes physical exercise 
and possibly vitamin D and calcium supplements may help to maintain muscle mass 
and bone mineral density, should be relatively safe for older obese persons 
(Newman et al. 2005; Zamboni et al. 2005; Villareal et al. 2006). 
Distinguishing between intentional and unintentional weight loss in older people is 
important, as their effects on health and functional capacity may be different and 
they stem from different backgrounds. Intentional weight loss is often due to life 
style modifications such as increased physical activity and/or decreased energy 
intake, whereas unintentional weight loss often reflects frailty (Fried et al. 2001b), 
severe diseases, underlying inflammatory process, insufficient nutritional intake or 
depressive symptoms (Wannamethee et al. 2000; Bales and Ritchie 2002). There is 
evidence that unintentional weight loss as well as another indicator of poor 
nutritional status in old age, underweight (BMI < 18.5 kg/m2), are associated with 
poor mobility (Davison et al. 2002; Larrieu et al. 2004) and predict subsequent 
functional limitation, disability, and mortality (French et al. 1999; Ferraro et al. 
2002; Lee et al. 2005; Mendes de Leon et al. 2006). Although the risk of 
underweight increases with aging (Thompson Martin et al. 2006) and is an important 
determinant of functional capacity, it was not possible to examine the association 
between underweight and walking limitation in the present study, because there 
were so few underweight persons in the sample. Respectively, due to the J-shaped 
association between BMI and functional limitation in old age, there was no 
justification for including underweight persons in the normal weight category. 
Therefore, in studies I–III underweight subjects were excluded from the analyses. 
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Similarly, subjects who had unintentionally lost weight (more than 10 kg in study I 
and more than 5 kg in studies II and III) during the past year were excluded from the 
analyses. 
Obesity, coexisting conditions and walking limitation 
The results of the present study indicate for the first time that obesity and coexisting 
diseases increase the risk of walking limitation and that overweight and coexisting 
physical impairments in middle-aged people predict later life walking limitation. 
These findings are in concordance with earlier studies which have reported a 
negative effect of excess body weight and coexisting physical impairment and 
disease on health outcomes (Ettinger et al. 1994; Rantanen et al. 2000). These results 
also show that obese persons are a heterogeneous group, which includes those who 
have diseases or physical impairments and those who are obese, but have no other 
diseases or physical impairments. Because obese persons with comorbidities or 
coimpairments are at substantially higher risk of walking limitation than obese 
persons with neither of these conditions, individuals with excess body weight should 
be carefully screened in health care for obesity-related diseases, as well as for 
physical impairments.  
From the preventive point of view, it is important to develop and evaluate proper 
interventions to decrease the risk of walking limitation due to comorbidities and 
coimpairments. Since the increased risk of walking limitation is a consequence of 
obesity and coexisting conditions, it is reasonable to assume that interventions 
aiming either to reduce excess body weight or to alleviate diseases or physical 
impairments are likely to reduce the risk of walking limitation. If this is the case, 
overweight middle-aged persons might greatly benefit not only from weight loss but 
also from physical exercise -related interventions designed to improve e.g. muscle 
strength or aerobic capacity. Furthermore, management of obesity-related diseases 
among older persons may prevent or reduce walking limitation associated with 
obesity. However, longitudinal studies and clinical trials are needed to verify these 
hypotheses related to coimpairment and comorbidity. 
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6.2 Methodological considerations 
Study samples and designs 
The major strength of the present study is the used data sets. The Health 2000 
Survey is one of the few comprehensive national health interview and examination 
surveys that exist in the world. The data are representative of the entire adult 
population in Finland and allow good generalizability of the results. A representative 
population-based data set has several strengths over clinical samples and studies on 
volunteers. First, a representative sample includes both men and women from 
different age-groups and different residential locations as well as healthy and 
diseased individuals. Secondly, if the sampling is based on population register data, 
as it was in the Health 2000 Survey, all individuals with similar basic demographic 
data (age, gender, residential location) have an equal chance of inclusion in the 
sample independently of their health or socioeconomic status. 
In order to obtain reliable results in a representative population-based study the 
individuals selected should participate in the study. In the Health 2000 Survey, a 
high participation rate (94%) was achieved, indicating that the findings would have 
high external validity. Several efforts were made to increase the willingness to 
participate, e.g. information campaigns, abbreviated health examinations at home or 
in institutions, an abbreviated telephone interview and a mailed questionnaire for 
those who did not participate in the study center or home examination, as well as the 
use of proxy respondents if the individual was not able to participate otherwise in 
the interview (2.6%, n = 78). There is evidence that non-participants often differ 
from participants in terms of age, health behavior and health status (Goldberg et al. 
2001; Jousilahti et al. 2005). Typically non-respondents are older, more diseased and 
disabled, and thus may be underrepresented such a study as the present one. 
However, because the participation rate was very high in this study, selective non-
participation is not likely to have markedly biased the results. 
In addition to a representative sample and high participation rate, to obtain reliable 
results from population-based studies, the sample has to be large enough. In the 
Health 2000 Survey power calculations were performed and after taking financial 
and temporal constraints into consideration, a sample of 8 028 persons was obtained. 
A two-staged stratified cluster sample was used to facilitate the organization and 
cost-effectiveness of the implementation of health examinations in the study 
municipalities, which were scattered around Finland. Despite the long distances 
between municipalities in the northern part of the country, good transportation links 
enable large-scale nationwide studies to be conducted in Finland. In contrast in, for 
example, the United States, the implementation of a reliable national health 
examination survey is far more difficult and expensive. 
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The data set used in Study IV, the Mini-Finland Follow-up Survey, is also 
internationally unprecedented due to 22-year follow-up period and the use of a 
health examination at both baseline and follow-up. Non-participation is particularly 
common in longitudinal studies, because people move out the area; die, or are 
unable to participate due to poor health status (Goldberg et al. 2006). In the Mini-
Finland Follow-up Survey, only 12% of the eligible survivors of the Mini-Finland 
Health Examination Survey were lost to the follow-up. These persons were older, 
had higher BMI, lower handgrip strength, and more medical conditions at the 
baseline in comparison to those who participated in the follow-up phase of the study. 
In addition, the prevalence of difficulties in squatting and running 500 meters at the 
baseline was higher among the drop-outs than follow-up participants. The follow-up 
participants were therefore leaner and showed better physical performance than non-
participants; thus the associations of BMI and physical impairments with walking 
limitation reported in this study are likely to be conservative rather than 
overestimated. Because large municipalities only were selected for the follow-up 
examination and since a substantial proportion of the initial cohort had died during 
22-year interval, it was not possible to control for the effects of selection on the 
invitation to the follow-up in the present study. 
General validity and reliability aspects 
To obtain reliable results, the methods and instruments used in a survey should be 
valid and repeatable. In the Health 2000 Survey, a health interview was 
implemented by trained interviewers from Statistics Finland and a health 
examination by trained professionals and calibrated instruments. To ensure the 
validity and repeatability of the measurements, written instructions were issued and 
a thorough training was organized before the study. During the data collection 
phase, the quality of the measurements was monitored with observations and 
repeated measurements. The reliabilities of the physical performance measures of 
handgrip strength and walking speed were excellent and moderately good, 
respectively. The reliability of the waist circumference measurement was excellent. 
The reliability of the questionnaires was improved by checking that the returned 
questionnaires had been properly filled in before acceptance at the examination site 
and by helping the subjects to fill in the missing answers whenever possible.  
Impaired cognitive status is one factor that may decrease the reliability of the results 
(Blaum et al. 2002). However, in this study all persons regardless of their cognitive 
status were included in the analyses. In the Health 2000 Survey, cognitive function 
was examined with an abbreviated Mini-Mental State Examination (MMSE) with a 
maximum score of 16 points (Folstein et al. 1975). Eleven percent of the participants 
aged 55 years and over had a value below 11 points. The majority of these persons 
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received 9 or 10 points in the test, suggesting mild cognitive decline. The outcome 
measure of this study, maximum walking speed over 6.1 meters, represents a routine 
physical task which should not be substantially affected by a mild cognitive deficit. 
As the person responsible for carrying out the tests observed that each participant 
performed the test in an acceptable manner, there is no reason to believe that the 
results are substantially affected by cognitive status. Furthermore, the tests were not 
performed for those six persons who were apparently unable to understand the 
instructions, even though a specific MMSE score cut-off points was not used as an 
exclusion criterion. 
Walking limitation 
In this study walking limitation served as the outcome variable, and it was based 
primarily on walking speed. The cut-off point for a walking speed indicative of 
walking limitation was chosen according to the ROC analysis. The analysis showed 
that 1.2 m/s had the greatest diagnostic accuracy of self-reported walking difficulty 
in walking 500 meters. In addition, the chosen speed also served as a proxy for the 
ability to cross a street safely at light-controlled intersection, if crossing starts at the 
moment when the green light for pedestrians goes out (pedestrian protection time), 
as is the case in Finland and the United States (LIVASU-95 1996; Langlois et al. 
1997). In other studies, several walking speed cut-off points have been used 
depending on the target group and on the way the walking test has been performed, 
e.g. walking with usual or with maximal speed. In the Women’s Health and Aging 
Study (e.g. Rantanen et al. 1999a) and in the Established Populations for 
Epidemiologic Studies of the Elderly (e.g. Guralnik et al. 1995) a cut-off of 0.4 m/s 
at usual walking speed was used to indicate severe walking disability, and was later 
found to predict subsequent disability (Guralnik et al. 2000). In the Health, Aging 
and Body Composition Study a usual walking speed of less than 1.0 m/s was used 
and found to be predictive of persistent lower extremity limitation, hospitalization, 
and death (Cesari et al. 2005a). Also Studenski et al. (2003) used a cut-off point of 
1.0 m/s and found it to predict decline in function and health. In fact, if usual 
walking speed represents a level of performance of about 70–80% of maximal 
speed, the speed of 1.2 m/s used in this study would correspond quite well with the 
speed used in the Health, Aging and Body Composition Study, making possible to 
compare the results. 
In this study as well as in the above-mentioned studies, the cut-off point for walking 
speed was the same for the whole study population. However, walking speed is 
partially explained by gender and body height and therefore men and taller persons 
tend to walk faster than women and shorter persons. Although height-normalized 
values for walking speed have been presented separately for men and women as well 
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as for different age-groups (Bohannon 1997), in real life traffic lights do not take 
into account the gender or age of pedestrians. Thus, each person regardless of age, 
gender or height has to be able to walk at a standard speed in order to cross the 
streets safely. 
By combining the information on low walking speed and self-reported walking 
difficulty, it was possible to obtain a more representative picture of the variation of 
walking limitation in the Finnish population. Using walking speed alone as an 
indicator of impaired mobility would have resulted in the exclusion of a number of 
people with walking limitation, because many of the most severely disabled and 
diseased persons were either not able or unwilling to take part in the measurements 
(Sainio et al. 2006). Although performance-based tests and self-reported difficulties 
provide partially discordant results (Guralnik et al. 2000; Simonsick et al. 2001b; 
Ferrucci et al. 2004), the current opinion in gerontological research is that these 
measures of physical functioning should be used as complementary measures 
(Guralnik et al. 1994; Cress et al. 1995; Sakari-Rantala et al. 2002). Consequently, 
several studies have been published  in which a combination of performance-based 
tests and self-reports in walking have been used (Rantanen et al. 1999a; Reuben et 
al. 2004). In addition to walking, the information regarding medical conditions was 
also mainly based on a clinical examination by a physician, but supplemented with 
self-reports in studies I and III (21% and 25%). In studies II and IV, only clinical 
diagnoses were used.  
Obesity indicators 
In this study, the majority of the analyses were performed using BMI as the measure 
of obesity. Information on BMI was obtained from a larger population (n = 2 895) 
than waist circumference (n = 2 632) or body fat percentage (n = 2 124). In addition, 
among these measures BMI is the only one which has internationally accepted and 
widely used cut-off points to indicate risk of ill health (World Health Organization 
2000). Categorizing different levels of obesity enables meaningful comparisons of 
weight status within and between populations, and the identification of individuals 
and groups at increased risk of adverse health or functional outcomes (World Health 
Organization 2000). However, in study II body fat percentage was mainly used, 
because in that study special emphasis was placed on low-grade inflammation, and 
adipose tissue has been reported to be an important source of inflammatory markers 
(Mohamed-Ali et al. 1997).  
The obesity measures used in this study were mainly based on objective 
measurements. Only a small proportion of the BMI values used in studies I (7%) and 
III (1%) were based on self-reported body weight or height. According to a 
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reliability assessment conducted in the Health 2000 Survey, the agreement between 
self-reported and measured weight (ICC = 0.98) and height (ICC = 0.95) was high, 
indicating that the effect of self-reports on BMI classifications was slight. In Study 
III self-reported recalled weights and height were used. Currently obese persons tend 
to underestimate and currently low-weight persons overestimate their previous 
weights (Stevens et al. 1990; Perry et al. 1995; Tamakoshi et al. 2003). However, in 
this study, the effect of obesity on recall accuracy was controlled for, because 
information about current obesity was included in the categorization of obesity 
history. Apart from body weight, other factors that might affect the accuracy of 
recalled weights include gender, race and recall period (Stevens et al. 1990; Must et 
al. 1993; Perry et al. 1995; Tamakoshi et al. 2003). To reduce the potential bias, 
these variables, excluding race, were controlled for in our models. However, there is 
evidence that people can recall their past body weights over a long period of time 
with a good accuracy. For example, Tamakoshi and colleagues (2003) compared 
self-reported weight at age of 25 years with previously measured weight among 
Japanese men aged 34–61 years. They found a strong correlation between the 
recalled and measured weights (r = 0.85). Other studies have also shown high 
correlations (r ? 0.80) between recalled and measured weight in young adulthood 
among middle-aged and older men and women (Stevens et al. 1990; Casey et al. 
1991), justifying the use of recalled weights. 
Analytical considerations 
The cross-sectional designs in Studies I and II make it impossible to draw 
conclusions about the causality of the observed associations. However, with logistic 
regression analysis and sequential adjustment for medical conditions and biological 
indicators, it is possible to obtain important information on the associations between 
the studied variables. Furthermore, as this study was observational it can only 
provide preliminary evidence about the association and the mediating factors 
between obesity and walking limitation. Nevertheless, the results of this study can 
still be used as a basis for hypotheses to be tested in experimental studies, such as 
randomized controlled trials. 
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6.3 Future directions 
Within the next few decades, the number of older obese persons is expected to 
increase rapidly in Finland and in other western countries for two concomitant 
reasons: the overall prevalence of obesity is rising and the number of older people 
living to very old age is increasing. Consequently, the number of persons with 
walking limitation caused by obesity or obesity-related conditions is likely to 
increase. Therefore, more studies are required on ways of preventing and alleviating 
obesity throughout the life-span, since avoiding excess weight gain is important in 
preventing functional limitation at older ages. More research is also needed on the 
effect of midlife weight loss and/or improvement in physical fitness on physical 
capacity in later life. Recent evidence suggests that moderate weight loss induced by 
combined dietary and physical exercise programs may improve mobility and 
physical functional capacity among older obese persons (Messier et al. 2004; 
Messier et al. 2005; Villareal et al. 2006). Further experimental research in 
collaboration with the behavioral sciences is, however, required to develop and 
evaluate feasible and effective interventions for older obese persons to prevent or 
decrease walking limitation. 
In the present study, one of the aims was to recognize some of the factors that 
mediate the effect of obesity on walking limitation. Because these analyses were 
based on cross-sectional data, prospective studies and intervention trials are required 
to confirm the suggested pathways from obesity through diseases, low-grade 
inflammation, and decreased muscle strength to walking limitation. In the future, it 
would also be useful to examine other potential mediating factors, such as physical 
activity, lower limb strength, aerobic capacity, and joint flexibility in order to find 
factors that could be intervened to prevent walking limitation among obese persons. 
Studying the association of body fat mass and muscle mass, and especially fat 
infiltrated to muscle with sophisticated body composition measures might also 
provide new insights into the functional limitation of obese persons.  
The association between obesity and walking limitation was examined in the present 
study from the epidemiological point of view, thus providing information about the 
phenomenon at the population level. However, at the individual level some obese 
persons are more prone to develop walking limitation than others. In addition to the 
factors covered in this study, more distant factors, such as genetic factors, may 
explain the large individual differences. Therefore, it would be interesting to use 
twin studies and quantitative genetic studies to examine whether there are genes that 
are associated with both obesity and walking limitation. Recognizing and targeting 
interventions at those persons who are genetically more vulnerable, and thus more 
prone to weight gain and functional limitation, might have a positive effect also at 
the level of public health.  
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7 MAIN FINDINGS AND CONCLUSIONS 
The main findings and conclusions of the present study can be summarized as 
follows:
1. In persons aged 55 years or older, high BMI, large waist circumference, and 
high body fat percentage were associated with increased risk of walking 
limitation in a progressive manner. Obesity was more closely associated with 
walking limitation in older women than in older men. 
2. Of the most common chronic conditions, knee osteoarthritis in women and 
type 2 diabetes in men were the strongest mediators in the association between 
obesity and walking limitation. In addition to diseases, low-grade inflammation 
and low muscle strength partially mediated the association between obesity and 
walking limitation.  
3. High BMI and physical impairments measured at middle age predicted walking 
limitation 22 years later. In addition, longer duration of obesity increased the 
risk of walking limitation among persons aged 55 years or older.  
4. Overweight or obese persons with coexisting diseases or physical impairments 
had a high risk of current or future walking limitation compared with the risk 
associated with excess body weight alone indicating that comorbidity and 
coimpairment have a negative effect on physical functioning.  
In conclusion, the results of the present study indicate that obesity and obesity 
duration throughout the lifespan as well as obesity and coexisting conditions are 
important risk factors for older persons’ walking limitation. The observations of the 
current study may be used as a basis when planning and targeting efficient 
interventions to prevent and alleviate walking limitation in older people. Future 
research using prospective and experimental settings is needed to confirm the role of 
diseases, low-grade inflammation, and decreased muscle strength on the pathway 
from obesity to walking limitation.  
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t b
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: m
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, c
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 m
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 d
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 m
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 c
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: m
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 m
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 c
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t p
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 c
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 m
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